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Abstract
Atherosclerosis is a leading cause of death in the United States, with 1 in 5 deaths (500,000
annually) attributable to coronary artery disease alone. While the disease processes are
not completely understood, it is believed that patient risk depends on a variety of factors
including lesion structure, biomechanical behavior, and morphological and chemical compo-
sition. Raman spectroscopy, based on spectral analysis of inelastically scattered photons, is
a nondestructive technique that yields detailed information about the chemical composition
of the sample being interrogated. Intracoronary Raman spectroscopy can be performed via
the use of a flexible, small diameter (< 2 mm) optical fiber probe to guide light to and
from the arterial wall in situ. The fact that Raman scattering has inherently low signal
intensity, combined with the need for a small diameter probe, makes it difficult to develop a
probe with sufficient signal-to-noise for robust plaque diagnosis. This thesis addresses two
approaches for increasing SNR: increasing Raman signal intensity and optimizing probe
design.
While most biological applications of Raman spectroscopy have been performed in the
"fingerprint" region (Raman shifts between 400 and 1800 cm-1), the high wavenumber re-
gion (2700 - 3100 cm- 1) offers distinct technical advantages, including increased Raman
signal relative to the fluorescent background and potentially less fiber background. How-
ever, the high wavenumber region may yield different molecular information and thus have
different diagnostic capability. In this thesis, we develop a benchtop Raman system capable
of acquiring Raman spectra in both wavenumber regions. In contrast to previous work,
which focused on plaque characterization based on the Raman spectrum from a single site
within the plaque, our system utilizes a line imaging paradigm, in which we acquire Raman
spectra at fixed intervals across the full cross-section of the plaque, creating a Raman line
image. We use this benchtop system to acquire a database of Raman line images and cor-
responding histology for over sixty plaque specimens. Using this database, we compare the
diagnostic capability of fingerprint and high wavenumber Raman spectroscopy for plaque
characterization.
Because of the small size requirement for an intracoronary probe, it is important to
optimize the optical probe design to maximize collection efficiency and thus increase SNR.
We develop and experimentally validate a simulation technique for modeling Raman probe
performance (collection efficiency and sampling volume), as an aid to optimizing probe
design. We also fabricate a 1.5 mm diameter probe and demonstrate it in vivo, using a
human-swine xenograft model, in which diseased human coronary arteries are grafted onto
a living swine heart. The results of this thesis provide insight on two approaches toward
achieving a clinically viable intracoronary Raman spectroscopy system.
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Chapter 1
Introduction
Over 16 million Americans are afflicted with coronary heart disease (CHD), and approxi-
mately one of every five deaths in the United States is caused by CHD, or -500,000 deaths
annually [1]. In the United States, the total economic burden of CHD is -$165 billion per
year in direct and indirect costs. Atherosclerosis is a complex disease, characterized by
the development of atheromatous plaques within the arterial wall. When a plaque is dis-
rupted, thrombogenic factors in the atheroma come into contact with the blood, initiating
the clotting cascade. The resulting thrombus can occlude flow, cause ischemia, and may
ultimately result in myocardial infarction and stroke [2]. The mechanism behind plaque
progression and disruption and how it relates to patient risk is not well understood, but le-
sion structure, molecular and chemical composition, biomechanical behavior, and functional
state are believed to be important. There is a growing need for diagnostic technologies that
can study these factors, including their clinical significance and temporal evolution, to gain
understanding of the disease processes and to assess treatment efficacy.
1.1 Atherosclerosis
The normal human coronary artery is composed of three layers, the intima, media, and
adventitia (Figures 1-1 and 1-2). Endothelial cells line the lumenal surface of the intima,
where they regulate the passage of molecules between the blood and the arterial wall. The
intima is a thin layer of connective tissue, primarily collagen and elastin, with a small
number of smooth muscle cells. A layer of elastic tissue, the internal elastic lamina, serves
as a barrier between the intima and the media. The media contains tightly packed layers
Process Endothelial Endothelial Matrixdysfunction activation Inflammation proteolysis Apoptosis Thrombosis
Internal elastic lamina
A Apoptotic cell /(*) Collagen fibril 0 Endothelial cell % Fibrin Macrophage
0 Platelet & Smooth muscle cell Oflj Cell-adhesion molecules 0 LDL - Cholesterol crystals
Figure 1-1: Cellular processes in the development of an atherosclerotic lesion. Reprinted
by permission from Macmillan Publishers Ltd: Nature Reviews Genetics [5], © 2006.
of smooth muscle cells, embedded in a matrix of elastin and collagen. The outermost layer
is the adventitia, consisting of mostly collagen [3].
1.1.1 Pathogenesis
Atherosclerosis is characterized by an accumulation of lipid and fibrous tissue in the arterial
wall. The cellular processes involved in the development of an atherosclerotic lesion are
illustrated in Figure 1-1. Normal endothelium is resistant to adhesion by leukocytes, but
triggered by risk factors such as smoking, poor diet, hypertension, hyperglycemia, and
obesity, endothelial dysfunction may occur, in which endothelial cells allow low density
lipoprotein to enter into the intima. This in turn stimulates cell-adhesion molecules, which
recruit monocytes to adhere to the endothelial wall and migrate into the intima [3-5].
Inside the intima, monocytes mature into macrophages and begin to engulf modified
lipoproteins. Lipid droplets, primarily cholesterol esters, accumulate in the cytoplasm, and
the lipid-laden macrophage is then termed a "foam cell", due to its foamy appearance
when viewed under a microscope [3,4]. This type of lesion is called a fatty streak, and is
characterized by the presence of macrophage foam cells, lipid droplets in the smooth muscle
cells, and T lymphocytes [4, 6].
Macrophages in the fatty streak release growth factors that stimulate migration and
proliferation of smooth muscle cells into the lesion. As these smooth muscle cells accumu-
late in the plaque, they synthesize extracellular matrix, leading to the development of a
fibrous cap [7]. At this point, lesion progression is largely regulated by inflammatory pro-
cesses. Inflammatory cytokines can induce macrophages to undergo apoptosis, creating the
cellular debris that forms part of the necrotic core characteristic of more advanced lesions.
Mediated by the inflammation response, lipid infiltration and macrophage accumulation
continue, contributing to the soft lipid in the necrotic core. These macrophages express
proteolytic enzymes that break down the fibrous cap. This process can ultimately lead to
the development of a lesion consisting of a lipid-rich necrotic core covered by a thin fibrous
cap [2].
Alternatively, clinical observations have shown that atherosclerotic lesions develop dis-
continuously [8]. It is thought physical disruption of a plaque and the resulting thrombosis
leads to a sudden expansion of the lesion. Three mechanisms for plaque disruption have been
identified: superficial erosion of endothelial cells, microhemorrhaging within the plaque, and
fracture of the plaque cap [9].
Superficial erosion is characterized by microscopic areas that lack functional endothe-
lium. This exposes subendothelial collagen and von Willebrand factor, and ultimately leads
to thrombus formation. Superficial erosion occurs commonly and is usually asymptotic [3].
Disruption of microvessels in the atheromatous lesion may also contribute to plaque
progression. Lesions may develop microvascular channels as a result of neoangiogenesis.
These microvessels are fragile and prone to microhemorrhage, which leads to thrombosis in
situ. This, in turn, leads to thrombin generation, which can stimulate smooth muscle cell
migration and proliferation. Additionally, activated platelets release growth factors that
stimulate more collagen synthesis by smooth muscle cells, potentially leading to a growth
spurt of the plaque [3].
The most common mechanism for plaque disruption is fracture of the fibrous cap. Ac-
tivated macrophages within the lesion can produce proteolytic enzymes that degrade the
collagen in the fibrous cap, which then weakens and becomes susceptible to rupture. Fis-
sure of the cap allows thrombogenic materials in the lipid core to come into contact with
coagulation factors in the blood, resulting in thrombus formation [4].
1.1.2 Stages of atherosclerosis
Once the initial atherosclerotic lesion has developed, it can progress discontinuously to
several different stages (Figure 1-2). In an early atheroma, the intima is thickened by a
lipid core covered by a fibrous cap. Often in these lesions, the vessel has expanded outward
to maintain a relatively constant diameter lumen. Through a combination of the processes
described in Section 1.1.1, this lesion can become a 'stabilized' plaque, with a small lipid
pool and a thick fibrous cap. Alternatively, the early atheroma can progress to a 'vulnerable'
plaque, characterized by a large lipid core, a thin fibrous cap, and inflammatory cells [3,5].
Rupture of the vulnerable plaque may lead to thrombosis and subsequent healing, creating a
thickened fibrous intima with a narrow lumen. Rupture may alternatively lead to occlusive
thrombosis, resulting in myocardial infarction.
1.1.3 Plaque stability
Our understanding of human coronary artery disease is in part derived from autopsy studies
of coronary plaques from patients who have died of heart attacks [10]. These studies have
reported evidence suggesting correlations between a plaque's histologic features and the
presence of thrombosis. Tissue sections obtained at culprit coronary thrombi show three
types of lesions: 1) the thin-capped fibroatheroma (TCFA), comprising a macrophage-rich,
thin fibrous cap overlying a core of necrotic debris [11,12], 2) the endothelial erosion [10,13,
14], which may be more common in younger patients, lacks functional endothelium, and may
contain higher concentrations of certain proteoglycans [15], and 3) the superficial calcific
nodule [10]. The distribution of the different types of plaques implicated in myocardial
infarction ranges from approximately 55-60% for TCFAs, 30-35% for erosions, and 3-7% for
calcific nodules [10].
Due to its relatively high prevalence, we focus on the TCFA, the most common of these
vulnerable plaques [16]. TCFAs exhibit a thin fibrous cap (< 65 - 150 tm) that contains
smooth muscle cells in a collagenous-proteoglycan matrix, infiltrated by macrophages and
lymphocytes. The fibrous cap overlies a lipid-rich core, comprised of large amounts of
extracellular lipid, cholesterol crystals, and necrotic debris. It is hypothesized that thin,
mechanically unstable fibrous caps may rupture when exposed to biomechanical stress,
exposing the large lipid-rich core to blood. Conversely, stable plaques exhibit thicker, more
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Figure 1-2: Stages of atherosclerosis. Reprinted by permission from Macmillan Publishers
Ltd: Nature Reviews Genetics [5], @ 2006.
R
robust fibrous caps and a high density of collagen and smooth muscle cells [11].
Although these autopsy studies have been valuable for determining histopathologic
plaque types associated with coronary thrombosis, it is not well understood which plaques
cause coronary events, why these plaques cause events, or when. For instance, TCFAs are
a frequent autopsy finding in aysmptomatic or stable patients and are found with equal
frequency in culprit and non-culprit arteries in acute coronary syndromes [17]. Moreover,
disrupted TCFAs have been found in 10% of non-cardiac deaths [17]. Recent findings of mul-
tiple ruptured plaques [18] and increased systemic inflammation in acute patients [19] has
challenged the notion of a single plaque type as the precursor for acute myocardial infarction
(AMI) [20,21]. The role of erosions is also somewhat controversial, with some believing that
reports on the relatively high prevalence of erosive plaques is a result of study population
bias, and differing opinions on the inflammatory nature of these lesions [13, 15, 22].
While vulnerable plaque remains an important hypothesis for explaining the pathogen-
esis of acute coronary thrombosis, it is clear that there is much we still do not understand.
For instance, in a single patient, many nonfatal plaque ruptures can occur without caus-
ing death or even symptoms [17]. Additionally, in one study of patients who experienced
sudden coronary death, only 60% had lesions with plaque rupture; the remaining 40%
showed superficial erosion [13]. High levels of C-reactive protein found in patients with
acute coronary events suggest that systemic and multi-focal arterial inflammation may be
as important as focal, vulnerable plaque features [23]. A body of evidence is growing to
suggest that plaque risk is multifactorial [21]. Lesion microstructure, molecular and chemi-
cal composition, biomechanical properties, and functional state are now all considered to be
important [2,3, 7, 9, 24, 25]. Unfortunately, these factors have been difficult to prospectively
study due to a lack of appropriate technologies for investigating them in patients. The
development of diagnostic technologies for studying these factors, including their clinical
significance and temporal evolution, is therefore merited.
1.1.4 Diagnostic modalities for atherosclerosis
Many technologies have been developed for examining atherosclerotic lesions [26,27]. While
non-invasive imaging methods, such as computed tomography (CT) [28-30] and magnetic
resonance imaging (MRI) [31,32] are continually improving, their resolution and capability
to determine plaque composition is limited. Angiography, the current gold standard in
clinical care, can measure lumen diameter, area, and flow resistance, but is insensitive
to changes in plaque burden that are masked by arterial remodeling [26]. Angioscopy,
which uses a white light endoscope to view the surface of the artery, enables detection of
plaque surface features such as color, but is unable to give any information about plaque
composition [33]. Cardiac magnetic resonance (CMR) non-invasively measures plaque area
and volume but has limited spatial resolution [26, 27]. Intravascular ultrasound (IVUS)
allows structural interrogation of the arterial wall at a resolution of about 100 jIm [26, 27].
Elastography is an image processing technique based on IVUS that provides a map of the
mechanical strain behavior of a lesion [34]. Electron beam computed tomography (EBCT)
measures calcium content [27]. Thermography measures temperature variations at the
surface of the arterial wall, under the hypothesis that heat from inflammatory cells increases
temperature locally at areas of vulnerable plaques [35]. Intravascular ultrasound (IVUS)
[36-39] and its more recent incarnation, Virtual Histology [40], can identify the presence
of calcium. However, their capability to reliably identify lipid pools is currently under
debate. Molecular contrast agents for MRI [41-44] and IVUS [45,46] are on the horizon,
but progress towards clinical studies with these techniques is encumbered by the lengthy
approval process associated with new exogenous diagnostic agents.
Optical coherence tomography (OCT) is conceptually similar to IVUS, but it utilizes
infrared light, which enables higher resolution images (-10 jtm) of the arterial wall [47].
Extensive ex vivo validation studies have shown that OCT can be used to determine the
presence of fibrous, lipid-rich, and calcified plaques [47-49]. OCT's strength is that it can
obtain microscopic images of the arterial wall, which provides the opportunity to visualize
structural features thought to be associated with high-risk plaques, such as macrophages,
thin fibrous caps, and lipid pools [47, 49-52]. While OCT is excellent for characterizing
plaque structure, it does not offer much direct compositional information.
The capability of investigating coronary plaques on the chemical and molecular level is
needed to gain a deeper understand of CHD. Spectroscopic techniques are attractive because
they have the ability to identify specific chemicals in vivo via optical fiber probes. Molec-
ular imaging using fluorescent labels is a very promising technique [42, 53, 54] but faces the
challenge of obtaining regulatory approval for new optical contrast agents. Autofluorescence
spectroscopy and time-resolved lifetime fluorescence spectroscopy are sensitive to the pres-
ence of naturally occurring fluorophores in the artery, such as elastin, collagen, NADH, and
ceroid, but are limited by the small number of fluorophores in the artery and strong absorp-
tion in blood, which distorts the fluorescence spectrum [55-60]. Reflectance spectroscopy
is sensitive to chromophores in the arterial wall, such as hemoglobin and p-carotene [61],
providing the basis for "yellow plaques" seen during angioscopy [62-64]. Vibrational spec-
troscopy techniques provide a means of probing the detailed energy levels of molecules in
the arterial wall. One such technique, near-infrared (NIR) spectroscopy analyzes absorption
to determine the chemical composition of the artery. Near infrared absorption spectroscopy
(NIR) has been demonstrated in vivo, but the broad nature of its spectroscopic features
currently limits its detection to lipid-containing regions within the intima [65].
Raman spectroscopy is based on spectral analysis of inelastically scattered photons [66].
Raman spectroscopy has several advantages over NIR absorption spectroscopy. Raman
spectra contain very sharp, distinct peaks compared to the broad peaks characteristic of
NIR spectra. As explained above, evidence suggests that important factors for studying
atherosclerosis are the presence of a fibrous cap (collagen, macrophages, lymphocytes),
necrotic core (extracellular lipid, cholesterol crystals, necrotic debris), smooth muscle cells,
and calcifications. It has been demonstrated that Raman spectroscopy is highly sensitive
to detecting the majority of these components [67-70]. Raman spectroscopy may be an
ideal tool for improving our understanding of coronary atherosclerosis, as it may provide
more information about different plaque constituents than any other diagnostic modalities
proposed to date.
1.2 Raman spectroscopy
When a photon interacts with a molecule it may either be absorbed, elastically scattered, or
inelastically scattered. Raman scattering is inelastic; the incident photon transfers energy
to the molecule, raising the molecule from its ground state to an intermediate virtual level.
As the molecule relaxes to a vibrational level with higher energy than the ground state,
a photon is emitted with less energy than the incident photon. This energy difference is
called the Raman shift, and it is traditionally expressed in units of wavenumber (cm-1).
Every molecule has several unique vibrational states, resulting in scattering of photons at
several different Raman shifts; thus the spectral features of the Raman scattered light can
be used to identify molecules with high specificity. Furthermore, the Raman spectrum of a
heterogeneous sample composed of several chemicals is simply a linear combination of each
component chemical's Raman spectrum, with relative weighting coefficients determined
by concentration and Raman scattering cross section (probability for Raman scattering)
[68,71].
Spontaneous Raman scattering is very weak - for a typical sample, about 1 in 1010
incident photons are Raman scattered [72]. Because inelastic scattering is a low probability
event, Raman photons comprise only a small portion of the light remitted from the sam-
ple, as compared to elastically scattered light and fluorescence. In human tissue, accurate
chemical characterization is challenging as the inherently low Raman signal is buried in the
background of these competing signals.
1.2.1 Biomedical Raman spectroscopy
Raman spectroscopy probes the vibrational modes of a sample, which depend on both the
molecular composition and molecular structure of the sample. Thus, Raman spectroscopy
may be sensitive to disease induced changes in biological tissue, even before such changes
are histologically discernible.
As a nondestructive optical technique, Raman spectroscopy requires minimal sample
preparation - the only requirement is to bring the sample close enough to the optical
apparatus. The use of optical fiber probes makes it possible to conduct Raman spectroscopy
on many biological tissues in situ, and for some tissues, non-invasively. Because of these
advantages, Raman spectroscopy has been studied for the detection and diagnosis of many
diseases [73], including skin cancer [74], breast cancer [75], cervical cancer [76,77], Barrett's
esophagus [78], bladder and prostate cancer [79], brain tumors [80], and atherosclerosis
[69,70, 81-85].
Instrumentation
In a typical dispersive Raman system (Figure 1-3), near-infrared laser light is focused onto
the tissue. Remitted light is collected by the focusing optics and filtered to remove the
elastically scattered light. The resulting autofluorescence and Raman scattered light is
directed into a spectrometer, where it is dispersed onto a CCD, and the spectrum is recorded.
Because the energy shift associated with Raman scattering is independent of the wave-
length of the excitation light, it is possible to choose an excitation wavelength that produces
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Figure 1-3: In a typical benchtop Raman system, laser illumination is reflected off a longpass
optical filter and focused onto the sample. Remitted light propagates through the lens to
the filter, which blocks the elastically scattered light from propagating to the spectrometer.
less fluorescence, maximizes tissue penetration, and minimizes tissue damage. Autofluores-
cence from the tissue can be orders of magnitude higher than the Raman signal. Near
IR excitation can minimize autofluorescence, so biological Raman spectroscopy is often
performed using excitation in the 700 - 900 nm range.
Raman shifts are typically measured in the wavenumber region from 400 to 1800 cm - 1
[68, 69, 81, 83, 86, 87], which is termed the "fingerprint" (FP) region because of its high
sensitivity for biologically relevant molecules. There has been recent interest in Raman
spectroscopy based on the "high wavenumber" (HW) region, from 2400 to 3800 cm - 1, which
may contain less molecular information but offers significant technical advantages [88].
Optical fiber Raman probes
Conducting biological Raman spectroscopy in situ often requires a Raman probe. A Raman
probe consists of one or more optical fibers, which guide excitation light from the laser to
the tissue and deliver Raman scattered light from the tissue to the spectrometer. The distal
tip of the optical fiber probe may contain optical elements that filter, focus, and collect the
light from the tissue.
A typical FP Raman probe utilizes separate excitation and collection fibers to avoid
generating a competing Raman background signal from within the fibers (Figure 1-4). Laser
light propagating through a fused silica excitation fiber generates a large Raman background
signal, so that both excitation light and fiber Raman are incident on the tissue. The tissue
then remits the tissue Raman photons, the elastically scattered excitation photons, and the
elastically scattered fiber Raman photons. As these three signals propagate through the
collection fiber, an additional fiber Raman component is generated. At the spectrometer
input, the elastically scattered excitation photons can be filtered out, but the fiber and
tissue Raman signals occupy the same wavelength range, and thus both contribute to the
overall measured Raman signal. The fiber Raman signal often has spectral features that
overlap with the tissue Raman signal, and in most cases the fiber Raman signal is much
higher in magnitude than the tissue Raman signal.
This background can be avoided by placing optical filters at the distal end of the fibers
[86,89,90]. On the excitation fiber(s), a narrow bandpass or shortpass filter is used to block
the fiber Raman signal from entering the tissue, so that only excitation light impinges on
the tissue sample. A longpass filter is placed on the collection fiber(s) to block elastically
scattered light remitted from the sample, allowing only Raman scattered light from the
tissue to propagate through the fiber(s) to the spectrometer.
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Figure 1-4: Raman probes for the fingerprint region require optical filtering to avoid con-
founding the biological Raman signal with the Raman signal generated within the fiber.
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Data analysis and classification
Biomedical Raman spectroscopy applications have primarily been focused on disease diag-
nosis, which requires the development of a diagnostic algorithm. The algorithm provides
a mapping from the multi-dimensional Raman spectrum to one of a small number (< 10)
of distinct classes, or diagnoses. Raman spectroscopy diagnostic algorithms are often per-
formed in two steps: dimension reduction and classification.
The measured Raman spectrum may consist of l1000 data points (corresponding to
the number of CCD pixels), so for further analysis it is convenient to reduce the dimension
of the data to a tractable number of parameters. Simple examples of dimension reduction
techniques include extracting the intensities of a carefully chosen subset of Raman bands, or
calculating ratios of specific Raman bands [77]. Another method of dimension reduction is
to model the Raman spectrum as a linear combination of a limited number of basis spectra.
The set of bases used in the model can be physically motivated, such that they correspond to
spectra of specific chemical [68, 70] or morphological constituents [83,91], or they may be a
numerically derived set of orthogonal bases, as in principal components analysis [81,92, 93].
When using physical bases, the weighting coefficients are found using a fitting algorithm
(typically a least squares algorithm), but for orthogonal bases, weighting coefficients are
found by simply computing the dot product of each basis with the spectrum.
Next, the output parameters from the dimension reduction step are used as the input
to a classification algorithm. Supervised classification is often used, requiring a training set
consisting of Raman spectra and corresponding disease diagnoses. Examples of classification
algorithms that have been previously demonstrated with Raman spectroscopy are linear
discriminant analysis [93], logistic regression [69, 70,81], and artificial neural nets [92].
1.2.2 Raman for atherosclerosis
Several researchers have investigated the use of Raman spectroscopy for diagnosing athero-
sclerosis [68-70, 81-87, 91,92]. Two physically motivated spectral models have been devel-
oped. The first model utilized basis spectra measured from purified chemicals found in the
artery, including delipidized artery (primarily collagen and elastin), free cholesterol, choles-
terol ester, triglycerides, calcification, and -carotene [68]. For the second spectral model, a
confocal Raman setup was used to acquire basis spectra of morphological structures found
Table 1.1: Several studies utilizing Raman spectroscopy for diagnosis of atherosclerotic
plaque have been reported. Raman spectra are modeled as a linear combination of chemical
bases (chem.) [68], morphological bases (morph.) [91], or principal components (PCA),
or reduced using the discrete wavelet transform (DWT). Where available, the number of
specimens and classification accuracy for the training and prospective data sets is given.
Author
Romer [70]
Deinum [81]
Buschman [69]
Salenius [82]
Motz [83]
Silveira [84]
Nogueira [85]
de Paula [92]
Artery
coronary
coronary
coronary
carotid/femoral
carotid/femoral
coronary
carotid
coronary
Model
chem.
PCA
morph.
chem.
morph.
PCA
PCA
PCA
DWT
Training set
N Accuracy
97 98%
97 94%
97 98%
167 -a
34 82%
60 88%
75 94%
> 93%40
> 91%
Prospective set
N Accuracy
68 94%
68 90%
68 94%
0 -
0
51 82%
0
> 92%20
> 89%
aThe authors do not report overall accuracy. The sensitivity and specificity
lipid was 92% and 53%, and for detecting calcium salts, 100% and 88%.
for detecting
in the artery, including internal elastic lamina, collagen fibers, smooth muscle cells, adventi-
tial fat, foam cells, cholesterol crystals, carotene containing crystals, and calcifications [91].
These models, in addition to models numerically derived using principal component analysis
(PCA), have been used to diagnose atherosclerotic lesions via Raman spectroscopy (Table
1.1).
In three related studies, a single dataset was analyzed using all three spectral models.
Fingerprint Raman spectra were acquired from a single site on 165 ex vivo coronary lesions
using a benchtop configuration. Lesions were irradiated with 350 mW of 830 nm laser light,
and Raman spectra were collected for between 10 to 100 seconds. The spectral acquisition
site was marked with ink and submitted for histological processing. Each specimen was
histologically classified into one of three general categories: nonatherosclerotic plaque (73
specimens in the training set and 26 in the prospective set), noncalcified atherosclerosis (9
in training set and 16 in prospective set), and calcified atherosclerotic plaque (15 in training
set and 26 in prospective set).
Based on this dataset, Romer et al. fit the spectra to the purified chemical based
spectral model, and using the resulting fit coefficients, diagnosed the lesions using logistic
regression. They report 98% accuracy in the training dataset and 94% accuracy in the
prospective dataset [70]. Deinum et al. used the same data set to derive basis spectra
using PCA. Fit coefficients for two principal components served as the input to logistic
regression, which yielded accuracy of 94% and 90% for the training and prospective datasets,
respectively [81]. Buschman et al. fit the dataset to the morphological spectral model and
used the fit coefficients with logistic regression to acheive accuracy of 98% and 94% for the
training and prospective datasets.
In a separate study, Salenius et al. acquired spectra of 167 carotid and femoral artery
lesions. After fitting the spectra to the chemical spectral model, the presence of diseased
levels of cholesterol and calcium salts were detecting using threshold tests on the fit coef-
ficients. They reported 92% sensitivity and 53% specificity for detecting lipid, and 100%
sensitivity and 88% specificity for detecting calcium salts [82].
Motz et al. performed Raman spectroscopy in vivo, acquiring 34 spectra during carotid
endarterectomy and femoral bypass surgeries. The spectra were fit to the morphological
model, and logistic regression was used to classify plaques as vulnerable or stable. Histolog-
ically, vulnerability was assessed using a scheme proposed by the authors, in which a vulner-
ability score was assigned based on histologic features such as the presence of thrombosis,
ulceration, and hemorrhage, the thickness of the fibrous cap, the diameter of the necrotic
core, and the presence and depth of foam cells. Using leave-one-out cross-validation, the
authors report sensitivity and specificity of 79% and 85% for detecting vulnerable plaque,
with an overall accuracy of 82% [83].
Silveira et al. acquired Raman spectra at single sites of 111 coronary artery specimens
and histologically classified the specimens into three categories: nonatherosclerotic, non-
calcified, and calcified. They derived a spectral model using PCA, and using discriminant
analysis based on the Mahalanobis distance, two principal components were used to classify
the specimens, with an overall accuracy of 88% in the training set and 82% in the prospec-
tive set. They report sensitivity and specificity of 90% and 83% for prospectively detecting
lipid rich, noncalcified plaques (n = 21) [84].
Nogueira et al. performed a similar study, acquiring spectra at single sites of 75 carotid
artery specimens and histologicaly classifying the specimens into the same three categories.
Again, two principal components were used to classify plaques using discriminant analysis
based on the Mahalanobis distance. They report overall accuracy of 94%, with sensitivity
and specificity of 89% and 96% for detecting lipid rich, noncalcified plaques (n = 19) [85].
de Paula Jr. and Sokki acquired Raman spectra at single sites of 60 coronary artery spec-
imens, which were histologically diagnosed into three categories: atheroma, non-pathologic
tissue, and calcified tissue. The authors compared two dimension reduction techniques, the
discrete wavelet transform (DWT) and PCA. Between 10 and 19 coefficients were used to
train and validate artificial neural networks, with overall accuracy of greater than 90% for
both DWT and PCA [92].
1.2.3 Catheter-based Raman spectroscopy for atherosclerosis
Conducting intracoronary Raman spectroscopy in vivo requires a catheter, consisting of
an optical probe placed inside a sheath that can be safely maneuvered inside the coronary
artery tree Figure 1-5). The optical probe itself is made up of one or more bundled optical
fibers that guide light to and from the distal optical elements that filter, focus, and collect
the light from the tissue. Towards the proximal end of the catheter, the fiber bundle is split
into excitation and collection fibers. The excitation fiber is coupled to the laser and the
collection fibers are coupled into the input of the spectrometer.
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Figure 1-5: A Raman catheter consists of one or more optical fibers to: 1) deliver laser light
to the artery, 2) collect emitted Raman light, potentially using distal optics, and 3) deliver
the collected Raman light to the spectrometer.
Several FP Raman probes have been developed for Raman spectroscopy of arterial tissue
(Table 1.2) [86, 94, 95]. All of these probes consist of a central excitation fiber surrounded
by a ring of collection fibers, with separate filters used for excitation and collection. The
fibers used are generally multimode fused silica fibers.
Shim et al. demonstrated a 1.5 mm diameter probe consisting of seven collection fibers
(300 gm core diameter) arranged around a single excitation fiber (400 gm core). Each
fiber was internally filtered with an individual filter placed 2.5 cm from the distal tip of
the probe. The collection fibers were beveled and coated with a reflective layer to increase
the overlap between the excitation and collection light cones. This forward-viewing probe
was demonstrated on rabbit aorta ex vivo [94]. A side-viewing version of this probe was
made, without beveled fibers, by incorporating a gold plated mirror oriented at 450 from
the optical axis. Raman spectra were acquired with the side-viewing probe in vivo in sheep
aorta [87].
Motz et al. fabricated a 2 mm diameter Raman probe consisting of 15 collection fibers
arranged around a single excitation fiber. All fibers had 200 gm core diameter. Two
separate optical filters were epoxied to the distal tip of the fibers: a central cylindrical
shortpass filter for the excitation fiber and an annular longpass filter for the collection fiber.
A 2 mm diameter ball lens was incorporated at the distal tip to maximize overlap of the
excitation and collection light cones [86]. This forward-looking probe was used in in vivo
during carotid endarterectomy and femoral bypass surgeries [83].
Komachi et al. fabricated a 0.6 mm diameter Raman probe consisting of 9 fibers with 114
jim core diameter, with 8 collection fibers arranged around a single excitation fiber. Similar
to the probe demonstrated by Motz et al., one cylindrical and one annular filter were epoxied
to the optical fibers. No modifications were made at the distal end of the probe to modify
the excitation or collection light cones. The forward looking probe was demonstrated on
rabbit aorta ex vivo [95]. Using a 450 mirror, the Raman probe was incorporated into a 2
mm diameter side-viewing catheter, which was used to measure Raman spectra of a lesion-
mimicking phantom [96]. They have recently reported a modified probe, incorporating
a lens with a hole drilled through the center, providing for lensing over the the collection
fibers only [97]. To date, this 0.7 mm diameter probe has not been demonstrated on arterial
tissue.
1.3 Toward an intracoronary Raman system
A successful in vivo Raman spectroscopy system must achieve sufficient signal-to-noise ratio
(SNR) for accurate data analysis and classification while utilizing a small (-1 mm) diameter
catheter. It must also have the ability to screen a large area of the coronary at high speeds
(< 1 s per point), be portable, and meet patient safety standards. The SNR is defined
as the ratio of the mean of a particular Raman band to its standard deviation, and is
both sample and system dependent. SNR is affected by 1) the magnitude of the Raman
Table 1.2: Several optical fiber Raman
Shim [94]
7 around 1
Fibers (400 gm core ex.
300 gm core coll.)
Filter
Lensing
Outer
diameter
Applications
1 filter per fiber
beveled collection
fiber tips
1.5 mm
In vivo sheep
aorta [87]
830 nm, 100 mW 30s
probes for arterial
Motz [86]
15 around 1
(200 jim core)
1 central filter
1 annular filter
ball lens
2 mm
In vivo human
femoral and carotid
(surgical field) [83]
830 nm, 100 mW, Is
tissue have been reported.
Komachi [95]
8 around 1
(114 gm core)
1 central filter
1 annular filter
none
0.6 mm
Ex vivo rabbit
aorta [95]
720 nm, 7 mW, -20 s
signal, 2) the collection efficiency of the optical fiber probe, 3) the magnitude of the Raman
background generated in the probe, and 4) the presence of shot noise due to the relatively
large fluorescence signal generated in the sample. Increasing the laser power or exposure
time will increase the total laser energy incident on the sample, with a corresponding increase
in the Raman signal. However there is an upper limit to the amount of energy than can be
safely delivered to the patient.
High wavenumber Raman
Several of these challenges may be addressed by implementing a significant change in the ba-
sic Raman system. In this thesis, we investigate Raman spectroscopy in the high wavenum-
ber (HW) region, which provides three important advantages. First, Raman signals in the
HW region are roughly three times greater than those in the FP region [88]. Second, very
little fluorescence is generated in this region, reducing the overall shot noise. Finally, fused
silica does not have Raman bands in the HW region. As a result, fiber background is
minimal and filters are not needed, simplifying catheter fabrication [88,98].
These factors indicate that HW Raman may result in increased SNR, allowing for faster
data acquisition. However, HW Raman spectroscopy detects different molecular vibrational
states than are seen in the FP region. An unpublished proof-of-principle study of HW Ra-
man in five coronary artery samples found that while calcification cannot be seen in the HW
region (2700 to 3100 cm- 1), there is high sensitivity to triglycerides, cholesterol, cholesterol
esters, and proteins [88]. Due to the significant technical advantages of HW Raman spec-
troscopy, a comprehensive investigation of its capabilities for chemical characterization is
merited.
One of the goals of this thesis is to develop a database of FP and HW Raman spectra with
correlated histology. In Chapter 2 we describe the methods used to create this database, and
in Chapter 3 we compare the diagnostic capability of Raman spectroscopy in the fingerprint
and high wavenumber regions.
Raman line imaging
Previously published work on Raman spectroscopy for atherosclerosis has concentrated
on assigning a diagnosis based on the Raman spectrum taken from a single site within a
lesion. However, this approach is limited because atherosclerotic lesions are complex and
heterogeneous, and a single site spectrum may not capture enough chemical information
to fully characterize the lesion. For this reason, we investigate a Raman line imaging
procedure, in which multiple Raman spectra are acquired, at fixed intervals, across the full
cross-section of the lesion. This line imaging paradigm is analogous to the way we expect
data will be taken with the intracoronary cathether.
By acquiring localized data across a larger area of the plaque than is traditionally used,
the data from the line imaging paradigm may enhance plaque classification algorithms. In
particular, it may become possible to extend the traditional 3-category classification scheme
to a more sophisticated scheme, based on the chemical content and spatial extent of the
entire lesion. For example, the ability to subdivide the "non-calcified plaque" category into
"necrotic core" and "non-necrotic core" plaques would be clinically relevant.
We have used the Raman line imaging paradigm on all of the specimens in the combined
FP/HW ex vivo Raman database. This paradigm has added new challenges in managing
the data. We describe the line scanning methods in Chapter 2.
Optical probe design
A key component of the intracoronary Raman system is the intracoronary catheter. In this
thesis we explore optimization of the optical probe design to increase collection efficiency.
Building on prior work in the field, we fabricate and characterize a prototype Raman probe
in Chapter 4. In Chapter 5, we convert the forward-viewing Raman probe to a side-viewing
catheter and demonstrate it in an in vivo xenograft model, in which human coronary arteries
extracted from a cadaver are grafted onto the heart of a living swine. In Chapter 6, we
describe an optical modeling technique for simulating probe sampling volume and collection
efficiency, which can be used for optimizing Raman catheter design.
Finally, we have concluding remarks in Chapter 7.
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Chapter 2
Ex Vivo Raman Database
In this chapter we describe the ex vivo Raman database, a database of Raman spectra
and coresponding histology for over sixty atherosclerotic plaque specimens obtained from
human aorta. Generating the database is a multiple step process that includes acquisition
and processing of Raman spectra and histological images, verification and validation of the
data, and pathological diagnosis (Figure 2-1). In this chapter, we describe the methods
used to build and visualize the database. Data analysis will be discussed in Chapter 3.
2.1 Data acquisition
2.1.1 Experimental setup
We have developed a benchtop Raman system that implements both high wavenumber
Raman spectroscopy and line imaging. Using a single fixed-grating spectrometer and CCD,
the system is capable of acquiring Raman spectra in both the fingerprint (FP) (600 - 1800
cm - 1 ) and high wavenumber (HW) (2600 - 3100 cm- 1 ) regions by sequentially illuminating
the sample with two separate laser sources. The system also incorporates line scanning,
physiological temperature control and automated depth focusing.
The Raman line imaging system is shown in Figure 2-2. The Raman spectra are detected
by a fixed-grating spectrometer (Holospec f/1.8, Kaiser Optical Systems; Ann Arbor, MI)
and a deep-depleted, back illuminated CCD (Pixis 400:BR, Princeton Instruments; Trenton,
NJ); this combination acquires spectra in the wavelength range of 830 to 1000 nm. When
illuminating the samples with an 830 nm diode laser (Process Insruments Inc.; Salt Lake
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Figure 2-1: Creating the ex vivo Raman database.
sample
Figure 2-2: Benchtop Raman line imaging system.
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City, UT), the system measures Raman spectra in the FP region (400 - 1800 cm-'), and
when illuminating with a 740 nm diode laser (Innovative Photonics Solutions; Monmouth
Junction, NJ), HW spectra are measured (1600 - 3300 cm- 1 ).
Light from the two fiber-coupled diode lasers was collimated, combined into a single
beam path using a dichroic mirror, and focused into a 100 tm core, multimode fiber with
0.26 NA (Polymicro Technologies; Phoenix, AZ). Two computer-controlled high speed me-
chanical shutters (Uniblitz, Vincent Associates; Rochester, NY) were placed before the
dichroic mirror to rapidly switch between the two excitation wavelengths. Light exiting the
common fiber was collimated and any Raman or fluorescence generated within the fiber was
removed using a laser line bandpass filter (Semrock LL01-830; Rochester, NY) at 830 nm,
or a longpass filter (CVI) for the 740 excitation beam. The laser light was then reflected off
a longpass filter (Semrock LP02-830RU) at a -10' incidence angle and focused on the sam-
ple using a f/2 calcium fluoride lens. Light returning from the sample was directed toward
the longpass filter by the same f/2 lens. The longer wavelength Raman signal and tissue
fluorescence passed through the longpass filter and were focused into the spectrometer. The
Holospec spectrometer had a 100 gm internal slit resulting in an average spectral resolution
of 8 cm - 1 .
Temperature control
The aortic specimen was mounted on a custom-made specimen mount, designed to main-
tain the specimen at a physiological temperature of 370 C (Figure2-3). Temperature was
maintained by flowing water through the mount from a thermostated water bath (NesLab,
Thermo-Fisher Scientific; Waltham, MA). Prior to line imaging, each specimen was pinned
to cork inserts to prevent movement during the scan, and the specimen was immersed in a
phosphate-buffered saline solution to prevent dehydration.
Raman line imaging
Line imaging of each aortic lesion was implemented by securing the specimen mount to
a computer controlled 3-axis translation stage. Each translation stage axis was equipped
with a linear actuator (LTA-HL, Newport; Irvine, CA) driven by a computer interfaced
controller (Newport ESP3000). Spectral line images were acquired in one direction (Figure
2-3). Raman spectra were acquired at discrete locations on the specimen, with a fixed
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Figure 2-3: Temperature-controlled specimen mount.
interval of 200 - 250 pm.
Automated depth focusing
The tissue surface height of an aortic lesion is typically nonuniform, so we have implemented
automatic z-focusing to ensure that all spectra are taken with the same distance between
the tissue surface and focusing lens, thus maintaining a constant beam diameter at the
surface. Depth focusing was implemented by maximizing the amount of specularly reflected
excitation light collected from the tissue surface (Figure 2-2).
The excitation light returning from the tissue was collected by the f/2 lens, collimated,
and reflected off the longpass filter, back into the incoming beam path (dashed line in
Figure 2-2). Since the returning excitation light is made up of diffusely and specularly
reflected components, an aperture was placed in the beam path to remove some of the
diffuse reflectance. The remaining light was directed toward a photodetector and focused
into a 100 gm pinhole via an achromatic f/2 lens. A LabView routine adjusted the focus
(z-axis) automatically to maximize the specular intensity recorded by the photodetector.
2.1.2 Spectral and histological data acquisition
The process of spectral and histological data acquisition includes tissue acquisition, plaque
selection, Raman line imaging and histological processing. Detailed notes were taken
through the acquisition procedures; these notes were later used for validation.
Tissue acquisition
Human aortic specimens were obtained from the Massachusetts General Hospital (MGH)
Autopsy Service and the National Disease Research Interchange. 1 Arterial tissue was har-
vested within 48 hours after death, and aortic segments were cleaned of excess connective
tissue and stored at -80' C until imaging.
Lesion selection
Prior to imaging, whole aortic segments were passively thawed, rinsed in PBS and stored
on wet gauze at 40 C until needed. Based on visual inspection, slightly raised lesions with
a yellow tint were selected for inclusion in the database.
A laser speckle imaging instrument was used to help identify necrotic core lesions. Laser
speckle imaging has been successfully demonstrated for identifying necrotic core plaques and
can be employed as a rapid qualitative method for screening lesions believed to have necrotic
cores or large lipid pools [99-101]. Although quantitative analysis of the speckle pattern was
not performed, the dynamic speckle pattern observed for necrotic cores and in particular
thin capped cores demodulates rapidly, in contrast to fibrous and calcified plaques, which
have more static speckle patterns.
Once a lesion was identified, it was prosected from the aorta, taking note of the direction
of blood flow and other landmarks, such as side branches. The specimen was then placed
in the sample mount, with the region to be line imaged aligned directly over the aluminum
bar (Figure 2-3). The tissue specimen was pinned to the cork inserts to prevent movement
and immersed in PBS to prevent desiccation during the scan. Each specimen was assigned
an identification number: UMD001, UMD002, etc.
1 Aortic specimens were obtained with approval from the Massachusetts General Hospital Institutional
Review Board (protocol #2006-P-002040/1).
Calibration spectra
Prior to specimen imaging, instrument calibration data was acquired. For wavenumber
calibration, the Raman standard acetaminophen was used, which has numerous well-defined
peaks. Calibration data for spectral response correction was obtained by diffusely reflecting
white light from a NIST-traceable, fiber-coupled tungsten source (Ocean Optics; Dunedin,
FL) off a barium sulfate sample placed at the focus of the excitation beam. Finally, the
power delivered by each laser source was verified by monitoring the signal strength of a
peak in the cyclohexane Raman spectrum.
Raman line scanning
For each specimen, FP spectra were acquired with excitation power of 100 mW (830 nm),
and HW spectra were acquired with excitation power of 70 mW (740 nm). Raman spectra
were acquired at each site for typically 110 frames with an integration time of 0.25 seconds.
Thus, each site was interrogated for 27.5 seconds before moving to the next position, 200
or 250 gm away. The start and stop positions of the scan were chosen such that the
excitation beam completely scanned through the whole specimen, beginning and ending on
the aluminum bar of the specimen mount (Figure 2-3). Because spectra acquired from the
tissue have different bands than spectra acquired with the excitation beam off the tissue, it
is easy to identify which spectra correspond to the beginning and end of the tissue, allowing
accurate registration of the spectral data to the histologocial sections.
Once both HW and FP Raman scans were complete, the PBS solution was removed from
the specimen holder and registration marks were burned into the lumen (Figure 2-4). For
this process, green ink was placed on the tissue surface directly under the excitation beam
and exposed for approximately 20 seconds, producing a small ink burn on the tissue surface.
Since the laser wavelength was strongly absorbed by the ink, the registration process caused
minor thermal damage to the tissue, resulting in tissue shrinkage on the edges. This can
be seen grossly as a concave feature at the edges of the tissue adjacent to the registration
marks (Figure 2-4). In histology sections, the tissue shrinkage appears as contraction of the
lumenal surface (Figure 2-5).
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Figure 2-4: Registration marks in gross pathology. Scale bar, 2.5 mm. (UMD087)
2.1.3 Histological processing
After the specimen was removed from the specimen mount, red ink was applied to the
starting edge of the image scan (Figure 2-4). The specimen was then placed in a labeled
tissue cassette and photographed with the specimen identification number visible (Figure
2-4(a)). A second, higher magnification photo was then taken (Figure 2-4(b)).
Once the gross pathology was photographically documented, the specimen was bisected
across the green registration marks. Two parallel razor blades were used to cut the back
tissue edge so that it was parallel with the front face. With the red edge oriented on the left,
the lower bisected half was fixed in formalin, while the upper half was frozen and reserved
for stains requiring fresh tissue.
All formalin-fixed specimens were placed in decalcifying solution for 2 - 4 hours, after
which they were rinsed in water and stored in formalin until being sent to the MGH Pathol-
ogy Service for routine histological processing. The paraffin embedded specimens were cut
into 5 tm sections and stained with trichrome and hematoxylin and eosin (H&E). Three
additional unstained slides were prepared for future staining, as necessary.
All histology slides were digitized at a native resolution of 20X, using the Aperio slide
scanning system (Aperio Technologies; Vista, CA). Digitizing the histology slides enables
correlation of the Raman line image data with lesions morphology as a function of position.
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Figure 2-5: Registration marks in the histological sections. Scale bar, 1 mm. (UMD087)
2.2 Data processing
Once the spectral and histological data for each specimen was acquired, several processing
steps were necessary to extract the Raman spectra from the acquired tissue spectra and to
register the spectra to sites on the histological image. All data processing routines were
implemented in MATLAB version 7.5 (The MathWorks; Natick, MA).
2.2.1 Spectral processing
Preprocessing
Preprocessing of the acquired raw data was necessary to extract the Raman spectrum from
confounding signals arising from the environment, the instrument, and fundamental noise
sources. Extraneous signals that were removed or minimized through processing include
cosmic rays (stray atmospheric radiation) impinging on the CCD, CCD pixel response non-
uniformity, and shot noise.
Preprocessing steps are illustrated for a representative specimen (UMDO87) in Figure 2-
6. The topmost black spectra show the raw data, consisting of 100 frames of data taken with
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Figure 2-6: Spectral preprocessing. Of the 100 frames of raw spectral data (blue), 3 frames
have spikes due to cosmic rays (green). The cosmic ray-filtered, frame-averaged data (blue)
exhibits very high frequency noise due to pixel-to-pixel variations in the CCD, which was re-
moved using a calibration factor (magenta). The resulting spectrum was filtered twice with
a Savitzky-Golay filter (red; for comparison, the non-pixel corrected spectrum is underlaid
in gray). The PRNU calibration factor is shown in Appendix A (Figure A-3).
an exposure time of 0.25 seconds each. In this example, the FP spectra were contaminated
by four cosmic rays, shown in green. Cosmic rays were removed using a threshold-triggered
temporal smoothing filter, and the resulting spectra were then averaged together to increase
signal-to-noise ratio, as shown in blue. Noise due to CCD pixel response non-uniformity
was removed by dividing each pixel by a calibration factor proportional to its quantum
efficiency, which was estimated a priori for the CCD and the illumination conditions. This
estimation procedure is described in detail in Appendix A. The corrected spectrum is shown
in magenta. For display, the spectrum was smoothed by applying a Savitzky-Golay filter
twice [102], as shown in red.
One preprocessing step that we did not perform is correction for the wavelength depen-
dent system response. The optical components in the Raman system, such as the lenses
and filters, as well as the CCD, have a wavelength-dependent response, which can result in
the measured relative intensity of two Raman bands being different from the actual relative
intensity. One method of correcting for this wavelength-dependent system response is to
derive a wavelength-dependent correction factor by measuring the spectrum of a white light
source. White light calibration data was acquired for the all the specimens in the database;
however, several of these calibration spectra exhibited unexplained variability. Thus, the
spectral response correction was not performed for the database data. This does not present
problems for the current analysis because all database data and spectral models were ac-
quired with the same Raman system. However the database data cannot be compared to
data acquired using a different Raman system without further calibration steps.
Wavenumber calibration
Calibration of the wavenumber axis was performed by mapping CCD pixel number to the
vibrational frequencies of a Raman standard. Acetaminophen was chosen as the Raman
wavenumber calibration standard due to the large number of vibrational bands covering the
fingerprint region [72]. Seventeen Raman bands were used for FP region, and a third order
polynomial was used to construct the calibration curve (Figure 2-7(a)). In the HW region,
four Raman bands were used, with a second order polynomial (Figure 2-7(b)). Wavenumber
calibration was performed independently for each specimen.
Background removal
The acquired spectra are composed of a small Raman signal on top of a large fluores-
cent background (Figure 2-8), which is likely due to fluorescence emission from structural
proteins in the tissue. Background removal in the FP region is challenging because the
background varies not only between different specimens but also within a single specimen.
One common approach to background subtraction is to estimate the background by fitting
the spectral data to a polynomial, and then subtracting the estimated background [83], but
this approach was not sufficient for our spectral data. For example, spectra taken from
five different sites of a single specimen are shown in Figure 2-8. These spectra illustrate
changes in both the fluorescence line shape and in the ratio of Raman-to-fluorescence. Vi-
sual inspection of the spectra in Figure 2-8(a) shows that simple polynomial subtraction is
not a robust method for extracting the Raman spectrum. The relatively high Raman-to-
background ratios in spectra 14 and 23 make it difficult to use a polynomial to estimate the
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Figure 2-7: Wavenumber calibration is accomplished by fitting selected peaks of ac-
etaminophen spectra.
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background, because the prominent vibrational peaks in the stronger Raman signal erro-
neously pull the polynomial fit upward. Furthermore, a single fifth or sixth order polynomial
cannot adequately represent the different background signal shapes seen within the speci-
men. While not all specimens exhibit this much intra-specimen variability, the background
spectra between different specimens do exhibit more variability than this.
We have heuristically developed a background subtraction routine that addresses the
observed variability in both the Raman-to-background ratio and the background line shapes.
First, we implemented a modified polynomial fitting routine that iteratively fits a polynomial
to the data while excluding sharp Raman peaks [103]. Second, instead of using a single
polynomial to fit the entire background spectrum, we fit the background to two distinct
polynomials and then performed a spline interpolation to combine them into a smoothly
varying background.
In the FP region (Figure 2-9(a)), the background was estimated by a three step process:
1) modified polynomial fits were generated over two distinct regions, from pixel number
240 to 800 with sixth order, and from pixel number 600 to 1340 with fifth order; 2) the
polynomials were combined and averaged together in the overlap region from pixel numbers
650 to 750; and 3) the intermediate background was sampled at every 20 pixels and spline
interpolated to create a smoothly varying background spectrum. In the HW region (Figure
2-9(b)), the background spectrum was estimated by simply fitting a third order polynomial
to the data over a disjoint region encompassing pixels 700 to 890 and 1100 to 1250.
2.2.2 Spectra-histology registration
Tissue spectra identification
The first step in registration is to determine which spectral sites in the Raman line image cor-
respond to the tissue, as opposed to the aluminum specimen holder. This was accomplished
by visually inspecting both the preprocessed data and the extracted Raman spectrum. The
presence of water in the spectrum as well as the absence or weakness of tissue bands in the
Raman spectrum indicates that a spectrum was taken over the aluminum bar. In this way,
the site numbers corresponding to the first and last tissue sites were identified.
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Figure 2-8: The preprocessed Raman spectra may have different background shapes, even
within the same specimen (UMD089). Scale bar, 1 mm.
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Figure 2-9: Raman spectra were extracted from the preprocessed data using a heuristic
background subtraction method.
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Figure 2-10: Spectra-histology registration. Each vertical region corresponds to a Raman
spectrum acquisition site. Black numbers correlate the histology section to the spectrum
number. The vertical lines are not intended to imply the actual sampling volume of the
spectral measurements.
Histology image preprocessing
For each specimen, the digitized slide was opened in ImageScope, the slide viewing software
companion to the Aperio slide scanning system. A low resolution TIFF image was saved,
and the image was imported into MATLAB, where it was oriented such that the red edge
was on the left of the image and the arterial lumen was at the top of the image (Figure
2-10).
Spectra-histology registration
The final registration step is to assign each Raman tissue spectrum to its spectral acquisition
site on the histology image. Because histological processing of thin sections can introduce
artifacts such as non-uniform shrinkage and curling, it was not sufficient to simply divide
the image into vertical bins. We have developed a registration process that accounts for
these histology artifacts. Fore each specimen, a curved line was manually drawn at the
boundary between the intima and media, to represent the curvature introduced by histo-
logical processing (red line in Figure 2-10). The histology image was then segmented into
N equal parts, where N is the number of tissue spectra identified for that specimen. Radial
lines were drawn perpendicular to the curved line to denote the individual spectral sites
where Raman spectra have been acquired.
2.3 Verification and validation
Before entering a specimen into the ex vivo database, the reliability of the spectral and
histological data was assessed through several measures. The rigorously standardized pro-
cedures and extensive documentation performed throughout data acquisition and spectral
and histological data processing enabled the development of an objective verification and
validation procedure. Data from each specimen was assessed in the following areas:
* Spectral quality. A specimen was rejected if the spectral data exhibited extremely poor
SNR, a high fluorescent background that saturated the CCD, or stray light. Addi-
tionally, the experimental notes were consulted for anomalies during data acquisition.
* Registration. Since accurate registration of the spectral data with the histology sec-
tions is a key focus of this database, specimens were rejected if the ink registration
marks could not be identified throughout all the histology processing steps. The gross
pathology photograph was examined to verify the presence of the registration marks
on the tissue. The paraffin embedded histology block was inspected for the presence
of green ink, ensuring that the thin sections were cut from the correct surface of the
specimen. The stained thin sections were also inspected for the presence of both green
and red ink. Additionally, the gross pathology photo was compared to the histology
block and the thin sections to ensure that specimens were not misidentified. Again,
the experimental notes were consulted to identify anomalies encountered during the
acquisition procedure. Specimens that did not meet all of these requirements were
rejected from the database.
* Histology quality. Specimens were rejected if the histological sections were uninter-
pretable, either due to poor sectioning or poor staining. Histology quality was assessed
by a pathologist who was blinded to the spectroscopic data.
These verification measures ensured that all of the specimens in the ex vivo Raman database
have reliable data.
2.4 Pathological diagnosis
A board-certified pathologist diagnosed each specimen using the trichrome and H&E stained
slides. A modified version of the classification scheme proposed by Virmani et al. was
used [11] (Table 2.1). Some specimens displayed heterogeneous lesions; in these cases the
slide was classified with the most clinically significant category. In some cases, additional
stains were requested and supplied to confirm a diagnosis, such as picrosirius red, which can
be used to quantify collagen content, and Movat's pentachrome, to establish the presence
of proteoglycans.
Table 2.1: Histological classification scheme used for the database. This scheme is adapted
from [11].
Category Description
Thickening of the intimal region. Predominantly collagen
Intimal IH and smooth muscle cells with < 10% lipid or foam cells
hyperplasia present. Intimal thickness should be less than -300 Lm
to be classifed as IH.
Fibrous lesions consisting predominantly of collagen and
smooth muscle cells. These lesions have negligible or no
lipid (< 40% lipid within the ROI). The thickening should
be greater than -300 jim to be considered FP.
Pathological
intimal thickening
Necrotic core
fibroatheroma
Calcified
PIT Lipid rich plaque with no visible necrosis.
NCFA Necrotic lipid rich core with overlying fibrous cap.
FC Lesions with calcified nodules.
In addition to providing a diagnosis, the pathologist was asked to identify histological
features such as necrotic core, calcification, and protein-rich areas. Using ImageScope's
annotation feature, morphological features were directly identified on the image (Figure 2-
11). Additional comments from the pathologist were noted within the software. ImageScope
also provides a calibrated scale for measuring the size of morphological features, such as the
thickness of a fibrous cap. All information was saved in an XML file, which was used for
later processing in MATLAB.
Digital capture of the histology image and the pathologist's diagnostic notes is a key
feature of the ex vivo Raman database, facilitating mining of the database.
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Figure 2-11: Using Aperio's ImageScope software, a pathologist has identified distinct re-
gions of a heterogeneous plaque (UMD022). The yellow box encloses a necrotic core region
and the blue box encloses a protein-rich region.
2.5 Creation of the ex vivo Raman database
The database was created using the methods described above. For each cadaver aorta that
was procured, several atherosclerotic lesion specimens were scanned with the Raman line
imaging system. The protocol for each specimen is summarized as follows:
1. Procure and prepare lesion specimen; document with notes.
2. Acquire calibration data.
3. Acquire Raman line image.
4. Prepare specimen histology.
5. Extract Raman spectra from raw data.
6. Register spectra with histology slide.
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7. Validate data quality.
8. Assign pathological diagnosis.
To date, ninety specimens from ten cadaver aortas have been scanned. Twenty-one
specimens were rejected from inclusion in the database during the validation step. Nine of
the rejected specimens were the first nine scanned specimens, representing a learning curve
and the need for minor adjustments to the protocol. A group of specimens from subject 8
were rejected, mainly due to quality concerns in the histology sections returned from MGH
Pathology. The remaining 69 samples were diagnosed by the pathologist (Table 2.2).
Table 2.2: Ex vivo Raman database disease distribution. Number of lesions.
Subject IH FP PIT NC CA Total
1 1 3 8 4 0 16
2 0 2 5 0 0 7
3 0 0 2 0 0 2
4 0 0 3 0 0 3
5 1 0 3 0 1 5
6 0 0 2 1 1 4
7 0 0 8 2 1 11
8 0 1 0 0 0 1
9 0 0 18 2 0 20
Total 2 6 49 9 3 69
The database includes 69 Raman line images from nine subjects. Because one of the
initial goals of this thesis is to more thoroughly characterize the broad class of "lipid-rich"
lesions, the database was deliberately skewed to include a large proportion of lipid-rich
specimens. Thus, lipid-rich lesions constitute 85% of the database specimens, while protein-
rich (collagen) and calcified lesions represent only 12% and 4%, respectively.
2.6 Visualization
The ex vivo database incorporates data from several different sources, including spectral
data in two wavenumber regions, histology sections, and histopathological diagnoses and
notes. We have developed a graphical user interface (GUI) that enables the user to visualize
the data in the database (Figure 2-12). For each spectral site, the GUI displays the acquired
raw spectra, the extracted FP and HW Raman spectra, and the corresponding site outlined
in the histology section. The spectral filenames are displayed in the upper box, and the
pathology diagnosis and any relevant notes are shown to the left of the histology image.
Check boxes allow the user to view the raw and processed spectra on a fixed intensity scale
and to view spectral model fits, residuals, and fit coefficients (to be described in Chapter
3). Using the "Back" and "Next" buttons in the upper right, the user can quickly navigate
through all the acquisition sites in the specimen.
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Figure 2-12: GUI for viewing the database.
The GUI has been an invaluable tool for managing and analyzing the data in the ex vivo
Raman database. The ability to quickly visualize all the data from an entire specimen on
a single screen has aided in correlating the spectral information obtained from the Raman
line images with the morphological information obtained from the histology images.
2.7 Conclusions
In this chapter, we have developed an ex vivo Raman database consisting of Raman line im-
age data and histological data from 69 aortic lesions. Raman spectra were acquired at fixed
intervals across each lesion, at physiological temperature, in both the fingerprint and high
wavenumber regions. A rigorous protocol was developed to ensure that all specimens had
good quality spectral data, good quality histological data, and most importantly, accurate
registration between the spectral acquisition sites and the histology image. The histology
sections and the pathologist's diagnosis and notes were digitally captured. All the spectral
and histological data was stored electronically, and a graphical user interface was developed
to enable visualization of all the data for a specimen on a single screen. In the next chapter,
we focus on the lesion characterization using the database data.
Chapter 3
Ex Vivo Lesion Characterization
Having created the ex vivo Raman database of correlated spectra and histology described
in Chapter 2, we turn our attention to characterizing atherosclerotic plaques based on the
Raman line images. In this chapter, we develop a set of physically motivated basis spectra
to aid in interpreting the tissue spectra. Each spectrum in the line image is fit to the
spectral model, and the resulting fit coefficients are used to diagnose lesions based on single
site Raman spectra and to correlate the spectral information in Raman line images with
the histological sections.
3.1 Spectral modeling
As discussed in Section 1.2, an important step in Raman spectral analysis is data reduc-
tion, the process of reducing the multi-dimensional Raman spectrum into a smaller set of
relevant parameters. In this chapter we model each tissue Raman spectrum as a linear
combination of physical basis spectra, an approach that has been successfully demonstrated
for characterizing atherosclerotic plaques [67,68, 70, 83, 91].
Baraga and Manoharan et al. determined that for arterial Raman spectra, most spectral
features can be adequately represented as a linear combination of the following chemical
components: collagen, elastin, cholesterol, cholesteryl oleate, cholesteryl linoleate, and cal-
cium hydroxyapatite [67, 104]. They created a basis spectra model using commercially
available preparations of these chemicals, and then experimentally determined the relative
Raman cross section of each chemical, resulting in a calibrated model capable of quanti-
tatively determining the chemical composition of a sample based on its Raman spectrum.
They experimentally validated the calibrated model using mixtures of collagen, elastin,
cholesterol, cholesteryl oleate, and cholesteryl linoleate and were able to use Raman spec-
troscopy to determine the composition to within 5 - 15% of the actual value.
Noting that the Raman activity of a commercially prepared chemical may not accu-
rately reflect the Raman activity of the chemical in situ, Brennan et al. refined the basis
spectra model, using basis spectra of chemical compounds extracted from human coronary
artery [68]. This model required seven components: three lipids, two proteins, calcium salts,
and p-carotene. The three lipids were free cholesterol, cholesterol ester, and triglycerides;
the cholesterol spectra were obtained from purified chemicals, while the triglyceride spec-
trum was measured after chemically extracting triglycerides from adventitial adipose tissue.
For the two protein spectra, noncalcified arteries were chemically delipidized and Raman
spectra were acquired. After examining several arteries, they isolated two representative
protein spectra that modeled all the spectra well. The calcium salt spectrum was obtained
by dissecting a calcified nodule from a diseased artery, and the -carotene spectrum was
measured from crystalline p-carotene. They applied this model to minced coronary artery
samples, using biochemical assays to determine the absolute concentration of each chemical
component. The Raman spectral model was capable of assessing chemical composition to
within a few percentage points.
Buschman et al. used a confocal Raman system to acquire basis spectra from the most
important morphological components of arterial tissue in situ [91]. From thin sections of
coronary arteries, they isolated and acquired Raman spectra for the following nine compo-
nents: internal and external elastic lamina, collagen fibers, smooth muscle cells, adventitial
fat, foam cells, necrotic core, cholesterol crystals, carotene containing crystal, and calcifi-
cation. The spectra for these morphological components were fit to a model consisting of
purified chemical spectra, similar to the models used by Baraga and Manoharan [67,104].
In this analysis, they did not use a calibrated model, and thus did not assess quantitative
chemical composition, only relative fit contribution to the Raman spectrum. They found
that elastic lamina are primarily composed of elastin and collagen (-2:1 ratio); collagen
fibers are primarily collagen; smooth muscle cells are primarily actin; and adventitial fat
is primarily triolein. Foam cells and necrotic core are very similar and are composed of
cholesterol linoleate, cholesterol, and collagen (-2:1:1 ratio); cholesterol crystals are pri-
marily free cholesterol and cholesterol linoleate (-2.5:1 ratio); carotene containing crystals
are overwhelmingly p-carotene; and calcifications are primarily composed of calcium hydrox-
yapatite. Additional chemicals were included in the biochemical model, including myosin,
tropomyosin, phosphatidyl choline, and calcium carbonate, but these contributed little to
the morphological spectra.
3.1.1 Physical basis spectra model
Based on the results of the previously developed models, we have created a spectral model
containing the following components: free cholesterol, cholesterol ester, triglyceride, pro-
teins, -carotene, and calcification. Where possible, we obtained basis spectra in situ (pro-
teins and calcification), but for the remaining components, commercially purified chemicals
were used. All spectra were acquired using the benchtop system described in Chapter 2.
After acquisition, the basis spectra were preprocessed as described in Section 2.2.1 and back-
ground removal was performed analogously to Section 2.2.1. The background-removed basis
spectra are shown in Figure 3-1. While the spectrometer acquires data in the wavenumber
range from 300 to 1840 cm-1 in the FP region and 1600 to 3300 cm - 1 in the HW region,
the basis spectra have been truncated to a smaller region. In the FP region, the spectra
are truncated to 804 - 1799 cm - 1 because the background removal procedure is unreliable
outside this region. In the HW region, we consider only the region between 2818 and 3021
cm-1, because this region exhibits high variability between the basis spectra. Beyond this
region, the HW basis spectra exhibit fiat tails.
Cholesterol is a specific molecule, so purified cholesterol (Sigma C8667, Sigma-Aldrich;
St. Louis, MO) was used to measure the free cholesterol Raman spectrum. The term
"cholesterol esters" describes cholesterol esterified to any one of several fatty acids. In our
spectral model, the class of cholesterol esters is represented by cholesteryl linoleate (Sigma
C0289). Triglycerides are represented in our model by glyceryl trioleate (Sigma T7140).
The lipid spectra are very similar to previously published spectra [71]. Both cholesterol and
cholesteryl linoleate exhibit a strong band at 1439 cm - 1 due to CH 2 bending. The C=C
stretching vibration of the sterol ring results in a band at 1671 cm - 1 in cholesterol, which
is shifted to 1659 cm - 1 in the cholesteryl linoleate spectrum. Several bands arise from
vibrations in the sterol nucleus, including the cholesterol bands at 958 and 873 cm - 1 and
the cholesteryl linoleate bands at 957, 922, and 878 cm-1. The glyceryl trioleate spectrum
also corresponds very well with published spectra [71], with prominent peaks at 1440 cm - 1
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Figure 3-1: Chemical basis spectra in the (a) fingerprint and (b) high-wavenumber regions.
Only the displayed wavenumber regions (FP: 804 - 1799 cm - 1 , HW: 2818 - 3021 cm - 1)
were used in the basis spectra model.
due to CH 2 bending, at 1656 cm - 1 due to C-C stretching, and at 1301 and 1265 cm - 1
due to =C-H bending.
The most important structural proteins to include in the spectral model are elastin and
collagen, but it is difficult to acquire Raman spectra of commercially purified elastin and
collagen due to the presence of a very large fluorescent background. Thus, we represent both
elastin and collagen using two protein spectra. First, we acquired spectra from normal swine
aorta ex vivo.1 Biochemically, swine aorta is primarily elastin and collagen, with the ratio of
elastin to collagen decreasing with increasing distance from the heart [105]. The swine aorta
used in our model was harvested close to the swine's heart, so we believe that our swine
spectrum is predominantly composed of elastin with an additional collagen component,
though we do not know in what proportion. The second protein spectrum included in
our model was acquired from a tissue-engineered cartilage sample2 and is predominantly
collagen [106].
Raman spectra of the two proteins are similar, with both exhibiting prominent bands
around 1450 cm - 1 due to the CH 2 bending mode of proteins, at 1664 cm - 1 due to the
amide I band, at 1264 cm - 1 due to the amide III band [107, 108], and at 1004 cm - 1 due
to phenylalanine [91]. Comparing the swine spectrum to that of internal elastic lamina
published by Buschman et al. [91], the swine spectrum has bands at 1136 and 1104 cm - 1
due to desmosine/isodesmosine, which is specific to elastin [109]. The swine spectrum also
has bands at 933 and 855 cm - 1, due to the C-C stretching mode of proline; these bands
are specific to collagen [91,109]. Thus, as expected, the swine spectrum is a combination
of elastin and collagen. The collagen spectrum is missing the elastin-specific band at 1104
cm - 1, and the 855 cm - 1 band is more pronounced relative to the swine spectrum, confirming
that the cartilage spectrum approximates pure collagen.
To obtain a spectrum representing atherosclerotic calcification in situ, we dissected a
large, exposed calcified nodule from an ex vivo human aorta specimen. The calcified spec-
trum is dominated by a band at 960 cm - 1, due to the symmetric PO3- stretch of calcium
hydroxyapatite. Another band at 1071 cm - 1 is attributed to the symmetric carbonate
(C 02-).
1Normal swine aorta was harvested from a swine sacrificed for another procedure, under approval from
the Massachusetts General Hospital's Subcommittee on Research Animal Care (protocol #2007N000041).
2The tissue-engineered cartilage sample was a generous loan from the Plastic Surgery Research Laboratory
at Massachusetts General Hospital.
The -carotene basis spectrum was acquired from crystallized f-carotene (Sigma Fluka
BioChemika 22040). The p-carotene basis spectrum exhibits three resonantly enhanced
bands at 1513 cm - 1 due to the C=C stretching mode, at 1157 cm - 1 due to the C-C
stretching mode, and at 1008 cm - 1 due to the C-H bending mode [110]. p-carotene in situ
is typically associated with lipids, which shifts the C=C stretching band to -1524 cm - 1.
This highlights one of the challenges in developing a physically motivated spectral model:
purified chemicals may behave differently in an artery in situ, leading to shifts, linewidth
broadenings, or intensity variations of the Raman bands.
Raman spectra in the high wavenumber region correspond well with published spectra
[88]. The Raman bands between 2800 and 3050 cm - 1 are attributed to CH stretching
modes. The free cholesterol and cholesterol ester spectra both have strong bands at 2867
cm - 1 , while the triglyceride spectrum has a corresponding band at 2852 cm - 1. In contrast,
the proteins exhibit a strong band -2940 cm-land a shoulder near 2990 cm - 1. Neither the
calcified nodule nor the p-carotene contained any prominent bands in the high wavenumber
region, so they are not included in the HW spectral model.
Our spectral model is missing a number of chemicals that are known to be present in
the arterial wall, including actin, phospholipids, and other cholesterol esters, particularly
cholesteryl oleate. While the absence of these components in the basis spectra model may
affect the accuracy of the decomposition, these components are not believed to contribute
much to the overall Raman signal from atherosclerotic plaque [91].
Orthogonality of the basis spectra
The accuracy with which we can fit an arbitrary arterial Raman spectrum to the basis
spectra model is determined in part by the degree of orthogonality between the bases.
Orthogonality between two vectors is assessed by calculating the correlation coefficient,
p= , (3.1)
where x and y are the two vectors of interest. We assess the orthogonality of the basis
spectra by calculating the correlation coefficient between each pair of chemical basis spectra
(Table 3.1).
In the FP region, free cholesterol and cholesterol ester are highly correlated with p
Table 3.1: Orthogonality of the basis spectra
(a) Correlation coefficients for the FP basis
Lipids
spectra (Figure 3-1(a)).
I Proteins I
AD Cd 
-
4- Q QD
free chol. 1.00 0.81 0.65 0.45 0.29 -0.08 0.16
Lipids chol. ester 0.81 1.00 0.85 0.68 0.49 -0.10 0.11
triglyceride 0.65 0.85 1.00 0.59 0.45 -0.13 0.03
elastin 0.45 0.68 0.59 1.00 0.82 -0.13 0.06
collagen 0.29 0.49 0.45 0.82 1.00 -0.17 0.08
/-carotene -0.08 -0.10 -0.13 -0.13 -0.17 1.00 -0.10
calcification 0.16 0.11 0.03 0.06 0.08 -0.10 1.00
(b) Correlation coefficients for the HW basis spectra (Figure 3-1(b)).
Lipids Proteins
free chol. 1.00 0.97 0.89 0.39 0.53
Lipids chol. ester 0.97 1.00 0.95 0.33 0.48
triglyceride 0.89 0.95 1.00 0.25 0.40
Proteins elastin 0.39 0.33 0.25 1.00 0.98Proteins collagen 0.53 0.48 0.40 0.98 1.00
collagen 0.53 0.48 0.40 0.98 1.00
0.81, and triglyceride is also highly correlated with cholesterol ester, with p = 0.85. The
two proteins are highly correlated with a correlation coefficient of p = 0.82. As a group,
lipids are moderately correlated with each other, but not correlated with the proteins. The
final two basis spectra components, -carotene and calcification, exhibit very low correlation
with all other components. Thus, we expect the FP basis spectra model to be capable of
accurately distinguishing between lipids, proteins, p-carotene and calcification, but it may
not be as accurate for distinguishing between the two proteins, or between the three lipids.
Not surprisingly, a similar pattern is seen in the HW basis spectra. The two protein
components are highly correlated (p = 0.98), which is is easily confirmed by observing
the striking visual similarities between the swine and collagen spectra in Figure 3-1(b).
Additionally, the free cholesterol and cholesterol ester basis spectra are highly correlated as
well (p = 0.97), which can also be visually observed (Figure 3-1(a)). However, the highest
correlation between the lipids and proteins in the HW region is relatively low at p = 0.53,
suggesting that the HW basis model is also suitable for distinguishing between the lipid and
protein components of an arterial Raman spectrum.
3.1.2 Spectral decomposition
We model each tissue spectrum, S(F), as a linear combination of the physical basis spectra,
a k S(3.2)
kcB
where S([) is the reconstructed tissue spectrum, Sk ( ) is the basis spectrum for component
k, ak is the weighting or fit coefficient for basis component k, and B is the set of basis
spectra. In the fingerprint region, BFp = {free chol., chol. ester, triglyceride, swine,
collagen, 1-carotene, calcification}, and in the high wavenumber region, BHW = {free
chol., chol. ester, triglyceride, swine, collagen}. Prior to spectral decomposition, each
basis spectrum was normalized to have unit energy over the wavelength region shown in
Figure 3-1. We define the residual as the difference between the tissue spectrum and the
reconstructed spectrum,
R() = S(i) - S(i). (3.3)
Each tissue spectrum, S(P), was preprocessed and had its background removed, but no
filtering was performed prior to decomposition. We solve Eq. (3.2) as a constrained linear
least-squares minimization problem, with the constraint that the weighting coefficients, ak,
must all be positive. The fit coefficients were found using a nonnegative least-squares routine
in MATLAB (isqnonneg).
Example spectra are shown in Figures 3-2, 3-3, and 3-4. The spectra in these figures
have been filtered for display, and the residuals have been offset for clarity. Fit coefficients
and normalized fit coefficients are shown for each sample. Since we have not attempted to
calibrate the spectral model to account for varying Raman cross sections, the normalized
fit coefficients do not indicate the physiological concentration of each basis component.
An example of a protein-rich spectrum is shown in Figure 3-2. This heterogeneous
specimen (UMD016) was diagnosed with pathological intimal thickening (PIT), containing
a protein-rich region (dark blue stained area) at the left edge of the sample that gradually
transitions into a more lipid-rich region (gray stained area). The basis spectra reconstruct
the tissue spectrum moderately well for both wavenumber regions. In the FP region, all
of the significant bands in the tissue spectra are represented by the bases, but the band
intensities do not all match, leading to peaks that can be seen in the residual. In particular,
the spectral model overfits the region between 900 and 980 cm - 1 . This is seen consistently
throughout the database and is possibly due to poor background estimation in the protein
basis spectra. In the HW region, the basis spectra fit the data well.
The normalized fit coefficients confirm that this spectral site is protein-rich, with high
normalized fit coefficients for the protein bases in both the FP and HW regions. However,
the swine and collagen fit coefficients are not consistent between the FP and HW regions.
The swine fit coefficient is 0.01 in the FP region and 0.1 in the HW region, while the
collagen fit coefficient is 0.68 in the FP region and 0.58 in the HW region. The discrepancy
highlights the difficulties encountered when attempting to decompose a spectrum into highly
correlated basis spectra.
An example of a calcified spectrum (specimen UMD045) is shown in Figure 3-3. The
calcified nodule is easily identified as the purple region in the H&E histology section. The
reconstructed fit spectrum accurately represents the PO3 - band at 960 cm - 1, which is not
surprising because that band is a strong feature that is orthogonal to all the other basis
spectra. Since the calcification has no signature in the HW region, the HW fit coefficients
represent only the relative contributions of cholesterol, triglyceride, and protein.
Finally, an example of a necrotic core spectrum (specimen UMD087) is shown in Figure
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Figure 3-2: Basis spectra fit for a fibrous region of a plaque (UMD016). The red arrow in the
trichrome image marks the spectral acquisition site, a protein-rich region (stained blue) of
a heterogeneous plaque diagnosed as pathological intimal thickening. The tissue spectrum
is shown with the reconstructed fit spectrum and the corresponding residual (offset). Raw
and normalized fit coefficients are given in the table. Scale bar, 1 mm.
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Figure 3-3: Basis spectra fit to a calcified region of a plaque (UMD045). A large calcification,
stained purple, can be identified in the H&E histology image. The red arrow denotes the
spectral acquisition site. The tissue spectrum is shown with the reconstructed fit spectrum
and the corresponding residual (offset). Raw and normalized fit coefficients are given in the
table. Scale bar, 1 mm.
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Figure 3-4: Basis spectra fit to a necrotic core plaque (UMD087). The red arrow in the
trichrome image denotes the spectral acquisition site. The tissue spectrum is shown with
the reconstructed fit spectrum and the corresponding residual (offset). Raw and normalized
fit coefficients are given in the table. Scale bar, 1 mm.
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3-4. There is a strong correspondence between the lipid and protein fit coefficients in the
FP and HW regions. Both regions are dominated by free cholesterol and cholesterol ester,
with a moderate protein component present. The reconstructed fit spectra represent all the
major peaks present in the tissue spectra in both regions.
3.1.3 Discussion
Peak Raman intensity in the high wavenumber region is consistently higher than in the
fingerprint region (at the 1440 - 1450 cm - 1 CH 2 bend), due to the differing Raman cross
sections between the CH 2 bending mode (FP) and the CH stretching modes (HW). Thus
the HW Raman spectra typically exhibit higher SNR than the FP spectra.
Additionally, the overall Raman intensity is very low for the protein-rich spectrum rel-
ative to the lipid rich spectrum. The protein-rich spectrum has peak intensities of only 112
counts at 1450 cm - 1 (CH 2) and 491 counts at 2937 cm - 1, while the necrotic core spec-
trum has peak intensities of 1685 at the corresponding 1439 cm - 1 band, and 4743 at 2934
cm - 1. This is consistent with the fact that the Raman cross sections for lipids are known
to be higher than the protein cross sections [104]. This suggests that Raman intensity may
be a useful metric for lesion characterization; however, Raman spectra acquired through a
catheter in vivo may be susceptible to intensity variation due solely to geometry. For ex-
ample, a Raman spectrum acquired when holding a catheter in contact with a lesion would
be greater in magnitude than a spectrum acquired with the catheter held 1 mm away from
the tissue surface. For this reason, we do not consider the signal intensity in this analysis.3
The P-carotene basis spectrum does not accurately represent the tissue spectra in the
1500 to 1540 cm - 1 region. In both the calcified and necrotic core samples (Figures 3-3
and 3-4), the band at -1520 cm - 1 is poorly fit by the 1512 cm - 1 band in the P-carotene
basis spectrum, giving rise to a sharp feature in the residuals. This can be explained by
considering that the P-carotene basis spectrum was acquired from a dry, purified powder,
which does not accurately represent the chemical state of 0-carotene in an artery in situ,
where it is generally associated with lipid domains, due to its highly lipophilic nature.
Fortunately, no other basis spectra have spectral features in the 1500 to 1540 cm - 1 region,
so the lack of an accurate basis in this region does not affect the other fit coefficients.
3It is possible to devise a clinical procedure that would yield reliable Raman spectra intensity information;
in that case, absolute Raman intensity is likely to be an important parameter for lesion characterization.
Furthermore, the other prominent feature of the -carotene spectrum, the band at 1156
cm-1, does fit the tissue spectra well, suggesting that the p-carotene fit coefficients are
trustworthy.
Overall, the FP and HW basis spectra models do not fit the tissue spectra perfectly, as
can be seen in the nonuniform structure that is present in the fit residuals. The FP model
fits seem to be more inaccurate that the HW model fits, possibly because the FP region has
several well-defined bands, while the HW region has fewer, relatively broad bands. For this
reason, accuracy of the model fits in the FP region may be more sensitive to errors in the
basis spectra. Basis spectra errors can arise from problems in the spectral data processing,
e.g. inaccurate background removal, and more importantly, from spectral shifts related to
basis spectra sample preparation and environment, as in the -carotene spectrum.
Fit coefficients for a Raman line image
We can learn more about the accuracy of the basis spectra model by examining the fit
coefficients for an entire line image. Fit coefficients for the heterogeneous PIT specimen
(UMD016) are shown in Figure 3-5. First we consider the protein fit coefficients. The
collagen fit coefficients in both the FP and HW regions exhibit the same trend, decreasing
dramatically over the region between x = 0 mm to x = 3 mm, which closely matches the
decrease of blue staining in the histology image. However, the swine fit coefficients are
not consistent; the FP coefficient is zero for most of the lesion, while the HW coefficient
is approximately 0.2. This discrepancy, combined with the high correlation between the
swine and collagen basis spectra in both wavenumber regions, suggests that the swine and
collagen fit coefficients are individually inaccurate. Thus, for the remainder of this analysis,
we define a single protein coefficient, which is simply the sum of the swine and collagen
coefficients.
The triglyceride fit coefficients in both the FP and HW regions remain relatively con-
stant, even in this heterogeneous plaque. This is true throughout the database, suggesting
that the triglyceride fit coefficient is not a useful diagnostic measure. Indeed, in biochem-
ical analysis of aortic plaques, Felton et al. report that regardless of plaque severity, the
triglyceride content remains relatively constant [24]. Thus, while triglycerides are an im-
portant contributor to the arterial Raman spectrum, triglyceride content is apparently not
a diagnostically relevant parameter, so we do not consider it in the remaining analysis.
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Figure 3-5: FP and HW normalized fit coefficient
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profiles for a heterogeneous PIT lesion
In the FP region, the p-carotene fit coefficient is highly correlated with the cholesterol
ester coefficient, a finding that is also seen throughout the database. This is not surprising
as p-carotene binds with cholesterol esters. While -carotene content is physically correlated
with cholesterol ester content, the absolute amount of p-carotene within a plaque strongly
depends on the patient's diet [111], and thus P-carotene fit coefficient is not a consistent
diagnostic parameter.
By fitting the tissue spectra to our physical basis spectra model, we have reduced the
Raman spectral data to only four parameters in the FP region (normalized fit coefficients
for free cholesterol, cholesterol ester, protein, and calcification), and three parameters in the
HW region (normalized fit coefficients for free cholesterol, cholesterol ester, and protein).
3.2 Plaque characterization based on single site spectra
In this section, we investigate the ex vivo Raman database with our physically motivated
spectral model, in the context of previously published studies [69, 70, 82, 83]. Mimicking
these previous studies, we use spectra taken from a single site to diagnose plaques into
three categories: non-lipid plaque, lipid-rich plaque, and calcified plaque.
3.2.1 Histo-pathological classification
A board-certified pathologist assessed the histology slides and identified and diagnosed
regions with relatively homogeneous morphology. For each region, the pathologist estimated
the percentage of lipid present. A lipid score of 50% was used as a histological threshold
for classifying samples as "non-lipid" (< 50%) or "lipid-rich" (> 50%) plaques. To ensure
independent sampling, only every third spectral site was used within each region, which
separates the spectral sites by 0.6 to 0.75 mm. Forty-six of the 69 specimens were included
in this analysis, yielding a total of 121 independent spectral sites, which we term the "single
site database." As classified by histology, this single site database included 51 non-lipid sites,
68 lipid-rich sites, and 2 calcified sites.
3.2.2 Fingerprint Raman classification
In the fingerprint region, we use a two-step approach for classification. In the first step, we
separate the calcified samples from the non-calcified samples by simply setting a threshold
on the calcification fit coefficient. Other researchers have found that a simple threshold can
diagnose calcified vs. non-calcified plaques with sensitivity > 81% and specificity > 88%
[82,112]. Because the single site database has only two calcified samples, the threshold was
arbitrarily set at 0.4 (Figure 3-6).
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Figure 3-6: In the FP region, a threshold test based on the normalized calcification fit
coefficient can be used to classify calcified vs. non-calcified plaques. A subset of the lipid-
rich samples were histologically classified as necrotic core; these are highlighted with a green
triangle.
In the second step, the remaining non-calcified plaques were classified into non-lipid and
lipid-rich plaques using a threshold test on the ratio of lipid-to-protein. This L/P ratio is
defined as
L/P = afree chol. + achol. ester (3.4)
Oprotein
Plaques with a L/P ratio greater than the threshold, y, are diagnosed as lipid-rich. A
receiver operating characteristic (ROC) curve was calculated for varying values of 7 (Figure
3-7). Choosing 7 = 2.7 results in a sensitivity of 88% and specificity of 84% for identifying
lipid-rich plaques. The area under the ROC curve is 0.87.
3.2.3 High wavenumber Raman classification
Because calcified nodules have negligible spectral features in the HW region, we cannot use
the HW fit coefficients to diagnose calcified plaques. Based on the histology, the pathologist
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Figure 3-7: FP threshold test for classifying non-lipid vs. lipid-rich plaques based on the
FP lipid-to-protein ratio. Choosing y = 2.7 results in 88% sensitivity and 84% specificity
for detecting lipid-rich plaques. A subset of the lipid-rich samples were classified as necrotic
core; these are highlighted with a green triangle.
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classified the two calcified sites as non-lipid plaques. To classify the samples into non-lipid
vs. lipid-rich plaques, we again use the L/P ratio defined in Eq. (3.4), calculated with
the HW fit coefficients. An ROC curve was calculated (Figure 3-8), and choosing - = 1.7
results in a sensitivity of 93% and specificity of 85% for identifying lipid-rich plaques. The
area under the ROC curve is 0.95.
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Figure 3-8: HW threshold test for classifying non-lipid vs. lipid-rich plaques based on the
HW lipid-to-protein ratio. Choosing 7 = 1.7 results in 93% sensitivity and 85% specificity
for detecting lipid-rich plaques. A subset of the lipid-rich samples were classified as necrotic
core; these are highlighted with a green triangle. The two calcified sites are marked in the
plot, but for this HW analysis, they were included in the non-lipid group.
3.2.4 Discussion
Both the fingerprint and high wavenumber regions are capable of identifying non-lipid vs.
lipid-rich plaques, with sensitivity and specificity similar to previous studies (Table 1.1).
The HW diagnostic algorithm performs slightly better than the FP algorithm, suggesting
that the HW spectral model is more accurate for distinguishing lipid vs. protein bases.
* non-lipid
* lipid-rich
* calcified t *
I. 0 . *
1.7 * - *
n
u  
* " 
l  
a
_ ~ U ** UU
'
This may be due to the higher degree of orthogonality between the lipid and protein bases
in the HW region vs. the FP region.
In the FP region there are seven sites with (L/P)Fpp = o, because the protein fit
coefficient for these sites is zero. Closer inspection of the spectra at these seven sites reveals
that one suffers from low SNR because of high autofluorescence from the tissue, three have
low SNR because the lesion is thin and protein-rich, resulting in low Raman signal intensity,
and three sites exhibit an unusual background signal that was not accurately subtracted
by the background removal algorithm. These sites could be automatically excluded from
the database analysis by using a metric based on SNR; these sites could then be termed
"non-diagnostic." The HW region does not exhibit similar problems, because HW spectra
have higher SNR and because background removal is easier in the HW region. Indeed all
seven of these samples are classified correctly in the HW diagnostic algorithm.
One disadvantage to the HW region is that it cannot detect the presence of calcifications
in the atherosclerotic lesion. By design, our ex vivo Raman database has a small number
of calcified lesions, so this does not affect the overall accuracy of the HW algorithm. How-
ever, the HW region's lack of sensitivity for calcification may be problematic for studying
atherosclerosis in vivo.
It may be possible to develop a classification algorithm that uses the fit coefficients
in both the FP and HW regions simultaneously, potentially improving the classification
accuracy. For example, a combined algorithm might first leverage the FP region's sensitivity
to calcification to classify the calcified plaques, and then use a weighted combination of the
FP and HW L/P ratios, with a higher weighting on the HW ratio to reflect its robustness
to low SNR.
3.3 Raman-histology spatial correlations
Compared to single site classification, analyzing Raman spectra over an extended spatial
region provides a more complete characterization of hetergeneous atheroclerotic lesions. In
this section, we consider the normalized fit coefficients for complete Raman line images.
A heterogeneous PIT specimen (UMD016) is shown in Figure 3-9. Based on histological
evaluation, the plaque is primarily protein-rich between x = 0 mm and x = 1.4m, where
the beginning of a lipid-rich region can be seen. Between approximately 1.4 to 3.4 mm, the
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Figure 3-9: A heterogeneous PIT lesion (UMD016), with normalized FP and HW fit coef-
ficient profiles. FP and HW lipid-to-protein ratios are shown in the bottom panel. Scale
bar, 1 mm.
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Figure 3-10: A calcified plaque, with normalized FP and HW fit coefficient profiles. Lipid-
to-protein ratios are shown in the bottom panel. Scale bar, 1 mm.
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Figure 3-11: A necrotic core plaque, with normalized FP and HW fit coefficient profiles.
Lipid-to-protein ratios are shown in the bottom panel. Scale bar, 1 mm.
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amount of lipid present increases, while the protein content gradually decreases. For the
remainder of the section, from 3.4 mm to the end (6.8 mm), the specimen is primarily lipid-
rich, but not necrotic. Spectrally, the same features are seen in the normalized fit coefficient
profiles. In the FP region, the protein coefficient starts at 0.86 at x = 0 mm and remains
relatively constant for the first 0.6 mm, before gradually decreasing to 0.2 at x = 3.2 mm and
remaining constant for the remainder of the sample. Both the free and esterified cholesterol
fit coefficients increase with increasing position. However, free cholesterol reaches a plateau
around x = 3 mm while the cholesterol ester fit contribution continues to increase. The FP
calcification fit coefficient is zero throughout the sample. Fit coefficients in the HW region
follow the same general trends as in the FP region. There is a discrepancy in the relative
cholesterol coefficients between 0 and 1 mm, but this occurs where the protein fit coefficient
dominates the spectrum, which makes the remaining fit coefficients unimportant. Both the
FP and HW L/P ratios correspond well with the histology.
An example of a calcified specimen (UMD045) is shown in Figure 3-10. As expected,
the calcification fit coefficient is very high in the purple, calcified region (x = 3.75 to
x = 5.25 mm). At the edge of the calcified nodule, a modest amount of lipid is seen
in the histology section between 2.5 mm and 3.75 mm, which corresponds well with an
increase in the cholesterol ester fit coefficient seen in both the FP and HW regions. The
cholesterol fit is relatively constant throughout the sample. Aside from regions where the
protein fit coefficient is very high, the free cholesterol and esterified cholesterol fit coefficients
correspond very well between the FP and HW regions. The protein coefficient in the HW
region spikes at 4.25 mm, in the calcified region, due to the lack of calcification signal in
the HW region. Both the FP and HW L/P ratios are elevated over the region of the plaque
where the intima is thickened.
In the necrotic core specimen (UMD087) of Figure 3-11, the protein fit coefficient accu-
rately represents the increased protein composition at the shoulders of plaque. As expected,
the L/P ratios are elevated over the lipid pool area. The behavior of the free cholesterol fit
coefficients is not consistent between the FP and HW regions.
Another heterogeneous PIT specimen (UMD089) is shown in Figure 3-12. The FP and
HW L/P ratios are consistent with each other, and they suggest that there is elevated lipid
between x = 1 and x = 3 mm. However, only a very mild increase in lipid content is seen
in the corresponding region of the trichrome histology section. Examination of the gross
pathology photograph (Figure 3-12(b)) shows a yellow, lipid-rich region just offset from the
histology section plane. The Raman sampling volume of the benchtop system used in this
study is several hundred microns in diameter, while the histology section is only 5 gm thick,
so it is likely that the elevated L/P ratio results from a lipid region of this heterogeneous
plaque that lies outside of the region shown in the histology section.
3.3.1 Discussion
In general, the FP and HW normalized fit coefficients consistently exhibit the same trends,
correlating well with the overall lipid and protein content of the lesions, as evaluated through
histology. In all specimens, the L/P ratios are also consistently highly correlated between
the FP and HW regions, confirming that both the FP and HW basis spectra models are
capable of determining the relative fit contributions of cholesterols and proteins. The FP
L/P ratio is generally greater than or equal to the HW L/P ratio, a finding that is seen
in all the examples shown, as well as throughout the remaining specimens in the database.
This apparent scaling between the two ratios may be due to differences in the Raman cross
sections between bands in the FP and HW regions, or possibly to inaccuracy in the spectral
model or in the fitting procedures.
For free cholesterol, the FP and HW fit coefficients are not consistent, with the HW
model most often underestimating the contribution of free cholesterol relative to the FP
model. While this may be explained by differences in the Raman cross section, the high
correlation between the basis spectra for free cholesterol and cholesterol ester in the HW
region (p = 0.97) suggests that the discrepancy is most likely explained by difficulties in the
model fitting procedures. Currently, for the specimens in the database, we have no external
gold standard for determining free and esterified cholesterol content, so we cannot assess
the accuracy of either region for making this determination.
3.4 Discussion
In this chapter, we have developed a physically motivated set of basis spectra to model
the tissue Raman spectra. The model includes the most important chemicals that con-
tribute to the Raman spectrum of arterial tissue: free cholesterol, cholesterol ester, triglyc-
eride, and proteins, and in the FP region only, 3-carotene and calcification. The lipid
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Figure 3-12: Normalized fit coefficient profiles (a) for a heterogeneous lesion diagnosed as
pathological intimal thickening (UMD089), with corresponding gross pathology photograph
(b). The lipid-to-protein ratio suggests elevated lipid between 1 to 3 mm, which is barely
discernible in the histology image. Red arrows in the photograph denote the ends of the
Raman scan lines and the presumed location of the histology section. Yellow, lipid-rich
material is present just to the right of the red arrows, suggesting that the histology section
barely missed the lipid-rich region. Scale bar, 1 mm.
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and J-carotene spectra were acquired from commercially purified chemicals: cholesterol,
cholesteryl linoleate, and glyceryl trioleate. Protein spectra were acquired from two sources:
ex vivo swine aorta, which is predominantly elastin and collagen, and tissue-engineered car-
tilage, which is primarily collagen. The calcification spectrum was acquired by dissecting a
large calcified nodule from an ex vivo human aorta. Actin, phospholipids, and other choles-
terol esters were not separately represented in the model, which may affect the accuracy of
the model.
The tissue Raman spectra are modeled as a linear combination of the basis spectra,
and the weighting coefficients for each basis are calculated using a constrained least squares
algorithm. The basis spectra are linearly independent, so the weighting coefficients can be
uniquely determined. However, confidence in the physical interpretation of the weighting
coefficients is related to the orthogonality of the bases. For example, consider two linearly
independent vectors, vi and v 2 . The vector z = vi + n, where n is a noise vector in the
span of vl and v2 , can be decomposed into vl and v 2 uniquely. However, if vl and v 2 are
highly correlated, only a small noise vector, n, is needed to cause z to look more like v 2
than vl. Thus the weighting coefficients for highly correlated basis spectra are not robust
to perturbations in the tissue spectrum, and the physical interpretation of these coefficients,
relative to each other, may be suspect.
For lesion characterization, we are concerned with distinguishing the protein group from
the lipid group and with distinguishing free cholesterol and cholesterol ester. Between
proteins and lipids, the spectral model in the HW region is more orthogonal (p = 0.53) than
the FP region (p = 0.68), which suggests that the HW region is better for distinguishing
lipid from protein, a finding that is also confirmed by the database data. For cholesterol
and cholesterol ester, the HW basis spectra are far more highly correlated (p = 0.97), than
the FP region (p = 0.81), suggesting that the HW spectral model will have more difficulty
distinguishing these two components than the FP model.
Both the FP and HW basis spectra models are capable of reconstructing the tissue
spectra in the ex vivo Raman database. The models accurately account for all the significant
bands in the tissue spectra, though in some cases the peak intensities are not accurate,
possibly due to problems with the data processing procedures and the incompleteness of
the spectral models. Nevertheless, the fit coefficients do accurately reflect observations in
the histology sections; coefficients for proteins, lipids, and calcification correlate well with
the morphology seen in the histology sections.
A subset of the spectral model fit coefficients were used for lesion characterization. Free
cholesterol and cholesterol ester were retained because of their importance in determining
disease state. The swine and collagen fit coefficients were summed into a single protein
coefficient. In the FP region, the calcification fit coefficient was also retained. Triglycerides
and p-carotene are not considered to be diagnostically relevant and thus were not used for
lesion characterization.
The database data was analyzed in two ways. First, we developed a diagnostic al-
gorithm based on single site analysis, which is analogous to previously published studies.
Independent sites were chosen from the database specimens and histologically classified
into non-lipid, lipid-rich, and calcified groups. We then used the Raman fit coefficients to
diagnose the sites into those categories. In the FP region, this was accomplished in two
stages. In the first stage, the calcified samples were classified by using a threshold test
on the calcification fit coefficient. The remaining non-calcified samples were then classified
by thresholding the L/P (lipid-to-protein) ratio. Since the HW region has no calcification
signal, only the L/P ratio was used. For detecting lipid-rich plaques, the L/P threshold test
has sensitivity and specificity of 88% and 84% in the FP region and 93% and 85% in the
HW region. These results are similar to previously published studies.
Second, the Raman line images were analyzed. Analyzing the fit coefficients over the
entire line image allows for better characterization than examining single site spectra. Even
without further data processing or a classification algorithm, it is easy to visually identify
the presence of a lesion and estimate its size based on the normalized fit coefficients alone.
Both the FP and HW regions are capable of detecting lipid-rich plaques based on the
L/P ratio, but the HW region performs slightly better for several reasons. First, HW Raman
signals have higher SNR, due to the Raman cross sections in the HW region being larger
than in the FP region and due to the presence of less fluorescence. Second, the HW spectra
are easier to fit to the spectral model. The HW spectra have few, relatively broad bands, so
the spectral model fitting procedure is more robust to errors in both background removal
and in determining the basis spectra. Background removal is also easier in the HW region
than in the FP region, due to decreased fluorescence and the HW region's relatively narrow
bandwidth. Finally, the basis spectra for lipids and proteins are more orthogonal in the
HW region, increasing the accuracy of the L/P ratio.
In contrast, the FP region is more susceptible to spectral model fitting errors. As noted
in Section 2.2.1, background removal is more challenging in the FP region. The FP region
is also more likely to have basis spectra errors, which may arise from spectral shifts related
to basis spectra sample preparation or from poor background removal in the basis spectra.
However, the FP region has a significant advantage over the HW region in being able to
identify calcified regions of the plaque. The FP calcification basis spectrum is orthogonal
to all the other basis spectra. Combined with the large Raman cross section for P 043, this
makes calcification easy to distinguish, even in minute amounts.
An ideal extension of Raman spectroscopy-based lesion characterization lies in deter-
mining the relative composition of the cholesterols, i.e. distinguishing between relative
contributions of free cholesterol vs. cholesterol esters, and if possible, between individual
cholesterol esters, particularly cholesteryl linoleate and cholesteryl oleate. As seen in Figure
3-1, the spectral differences between the cholesterol and cholesteryl linoleate basis spectra
are subtle, but the FP region, with p = 0.81 for these bases, is more likely to be able to
make this distinction than the HW region (p = 0.97). Without having validated the data
processing and spectral modeling procedures, we cannot confidently claim that our current
spectral model is capable of making this distinction. Using Raman spectroscopy to analyze
cholesterol content will require further development, particularly in creating basis spec-
tra that accurately represent Raman activity of the cholesterol constituents in situ and in
carefully validating the preprocessing, background subtraction, and spectral decomposition
procedures.
External validation of the Raman spectroscopy results is essential to further developing
this technique. In particular, the data processing steps, including background subtraction,
and the spectral modeling need to be validated with a method other than histology. While
Raman spectroscopy is sensitive to molecular composition and molecular structure, histol-
ogy assesses the microscopic organization and orientation of the cellular structure. It is not
clear that there is a one-to-one correspondence between a lesion's molecular composition
and cellular structure, especially at different time points during lesion development.
An alternate validation method, which is left for future work, is to correlate the Raman
spectra and fit coefficients with chemical composition via biochemical assays, similar to
studies published by Baraga and Brennan et al. [67, 68]. However, biochemical assays
require chemical processing of a relatively large volume of tissue (> 1 mm3), which may
preclude direct validation of the Raman line images.
An important limitation of the current study is the use of two-dimensional histology
sections to correlate with the three-dimensional Raman sampling volumes. Raman spec-
troscopy provides a bulk measurement with a sampling volume on the order of 1 mm3 . Due
to the heterogeneous nature of atherosclerotic lesions, a single thin histology section cannot
completely characterize the morphology of a three-dimensional Raman sampling volume.
This limitation can be overcome in future studies by obtaining serial histology sections
throughout the Raman sampling volume.
The use of histology as the gold standard for lesion diagnosis imposes another limitation
on the development of Raman spectroscopy for diagnosis. Histological sections are used by
pathologists to diagnose lesions into discrete categories, but a limited number of discrete
categories may not be able to adequately characterize the wide range of atherosclerotic
lesion types typical of a complex disease. Furthermore, histological sections provide a
snapshot of lesion morphology at a single point in time, but it is possible that lesions at
different stages of development may look morphologically similar while having different
chemical signatures. Raman spectroscopy, being sensitive to both molecular composition
and molecular structure, may be able to detect pathological changes in tissue before they
are visible in histology.
3.5 Conclusions
In this chapter, we have developed a physically motivated basis spectra model to decom-
pose the Raman spectra into lipid, protein, and calcification constituents. After fitting
the data to the spectral model, we classified single site Raman spectra into non-lipid and
lipid-rich categories, by thresholding the ratio of the lipid fit coefficient to the protein fit co-
efficient. In both the fingerprint and high wavenumber regions, the resulting sensitivity and
specificity for detecting lipid-rich plaque is comparable to previously published fingerprint
Raman studies. By looking at fit coefficient profiles for Raman line images, it is possible to
determine the presence and size of an atherosclerotic lesion. In terms of diagnostic capabil-
ity, only the fingerprint region is able to identify calcifications, but both the FP and HW
regions can distinguish between non-lipid and lipid-rich plaques.
Chapter 4
Raman Probe
Intracoronary Raman spectroscopy requires the use of a flexible, small diameter (-1 mm)
fiber optic probe. The need for two separate channels with distinct optical filters at the
catheter's distal tip presents a significant challenge for Raman probe fabrication. While
several FP Raman probes have been demonstrated for atherosclerosis, most have not been
suitable for intracoronary Raman spectroscopy because they were either too large and in-
flexible to be introduced into human coronary arteries or have not had sufficient optical
throughput. In this chapter, we describe a prototype Raman probe, a miniaturized version
of the previously demonstrated Raman probes that is capable of acquiring spectra in both
the fingerprint and high wavenumber regions.
4.1 Design and fabrication
4.1.1 Fiber bundle
One way to increase the signal collected by the probe is to have as large a collection area
as possible, through the use of large diameter multimode fibers. However, larger diameter
fibers are stiffer than smaller diameter fibers, decreasing probe flexibility. For this reason,
our probe uses 100 gm core diameter fibers, which provide a tradeoff between large area and
small bend radius. Similar to the previously demonstrated probes, our design consists of a
ring of six collection fibers arranged around a single excitation fiber. All fibers were identical,
low-OH silica-silica fibers, with an acrylate buffer (Polymicro Technologies; Phoenix, AZ).
The fibers had a 120 gm cladding diameter, which enabled the use of standard off-the-
shelf fiber optic components and tools. The acrylate buffer diameter was 160 gm and the
numerical aperture of the fiber was 0.26.
4.1.2 Optical filter
As described in Section 1.2.1, one of the challenges in creating a fingerprint Raman probe
is the need for optical filtering at the distal tip of the probe to reduce the amount of
background signal generated in the fiber. The traditional approach is to filter the excitation
fiber with a shortpass or bandpass filter, which blocks the fiber background from entering
the tissue. A longpass filter is placed over the collection fibers, which allows only the Raman
and fluorescence signals from the tissue to propagate back to the spectrometer. Blocking
the elastically scattered excitation light from entering the collection fibers prevents the
generation of an additional fiber background signal. Dielectric interference filters, composed
of multiple thin films of dielectric material deposited onto a fused silica substrate, can
achieve high transmission and high extinction with a sharp transition edge, and are an ideal
solution for Raman spectroscopy. However, the need for two separate optical filters in a
small diameter (-1 mm) probe has been a significant engineering challenge for intracoronary
Raman probe development.
Previous researchers have fabricated Raman probes utilizing filters deposited on two or
more separate substrates. Shim et al. cut individual filters for each of the eight fibers in
their probe, with each filter being a -300 jtm diameter disk [94]. Motz et al. simplified
the fabrication process by using a combination of two separate filters, a central disk and
an outer annulus. The shortpass filter disk had a 500 jim diameter and was 1 mm thick.
The annular longpass filter had an inner diameter of 700 im and outer diameter of 1.75
mm [86]. Both of these probes are unsuitable for intracoronary use because they are not
flexible enough and are too large in diameter.
Using a similar approach of a central shortpass filter disk and an annular longpass filter,
Komachi et al. demonstrated a Raman probe with much smaller dimensions. The central
filter was 150 gm in diameter, with a thickness of 150 gm. The annulus had inner and
outer diameters of 200 gm and 500 jim, and the thickness was 100 jm [95]. The fabricated
Raman probe was only 600 tm in diameter, but fabrication of the filters at this size scale
was a technically challenging process, requiring specialized equipment and expertise.
We have circumvented this difficulty by using photolithography to deposit the shortpass
and longpass filters directly onto a single fused silica substrate (BARR Associates; Westford,
MA). The central region of the filter is a 200 gm diameter shortpass filter with a cutoff
wavelength of 830 nm (Figure 4-1), while the outer annular region is a longpass filter with
a cutoff of 860 nm. Because of current limitations in the photolithography process, there is
a 40 - 50 gm dead space between the two filter regions. The outer diameter of the filter is
775 gm, and the thickness of the fused silica substrate is 600 gm.
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Figure 4-1: Patterned filter. In (a) the longpass filter is deposited in the outer annulus
while the shortpass filter is located in the center. The gap between the two filters is clearly
visible.
The shortpass and longpass filters have excellent spectral response (Figure 4-1). The
shortpass filter has transmission of 83% at the FP excitation wavelength (830 nm), and
79% at the HW excitation wavelength (740 nm). The shortpass filter effectively blocks the
fiber background with transmission less than 0.05% in the wavelength range 850 - 1000 nm.
The outer annulus longpass filter transmits the returning Raman light (between 866 - 1100
nm) with transmission greater than 80%, and transmits less than 0.01% of the elastically
scattered light to the collection fibers.
4.1.3 Probe assembly
To assemble the fiber bundle, the seven fibers were first cleaved to provide a flat fiber face.
The fiber faces were aligned and bundled together using medical grade heat shrink tubing
(Advanced Polymers Incorporated; Salem, NH). Because the fibers are identical in diameter,
they self-assemble into a 6-around-1 configuration. However, to avoid conflict with the dead
space of the filter, the outer ring of fibers was deliberately spaced farther from the central
fiber than necessary. To retain the self-assembling property, a short length (-1 cm) of
heat shrink tubing was placed at the distal end of each fiber to increase the effective fiber
diameter in the bundled region. In the final assembled bundle, the center-to-center distance
between the fibers is approximately 200 gm.
(a) Side view (b) Front view
Figure 4-2: Prototype Raman probe. The forward-viewing Raman probe consists of a fiber
bundle bonded to a patterned dielectric filter. In (a), the filters are bundled together with
black heat shrink tubing and epoxied to the filter. In (b), the fibers have been illuminated
with overhead room lights. The central fiber appears orange due to the shortpass filter,
while the collection fibers appear purple due to the longpass filter. The outer diameter of
the filtered bundle is 775 gim. Rule marks in (a) are 100 pm apart.
The fiber bundle was then epoxied to the filter, with the thin film surface in contact with
the fiber face. To align the fiber bundle with the filter, both the filter and the fiber bundle
were mounted in a nanopositioning stage (Thorlabs; Newton, NJ), and a helium-neon laser
was coupled to the proximal end of the excitation fiber. The He-Ne beam is reflected by the
annular longpass filter, so by visualizing the assembly under a microscope, it was possible
to center the excitation fiber over the shortpass filter. Medical grade epoxy (Loctite Hysol
M-31CL, Henkel; Dusseldorf, Germany) was used to bond the fiber bundle and filter (Figure
4-2).
Proximal to the heat shrink tubing, the fibers were approximately two meters long. The
Raman probe was modeled after commercially available intracoronary catheters, which have
a working length of -1.5 m. Thus, 1.5 m of the distal portion of the the optical fibers were
loosely bundled together in plastic tubing. The proximal 0.5 m of fiber was split into two
channels; the single excitation fiber was coupled to the lasers and the six collection fibers
were coupled to the spectrometer. Both sets of fibers were inserted in fiber optic furcation
tubing for protection.
The outer diameter of the forward-viewing Raman probe is 775 jim and is currently
limited by the outer diameter of the filter module. The fiber bundle diameter is -560 jm,
though this could be reduced by placing the outer ring of collection fibers closer to the
central excitation fiber and re-patterning the filter accordingly. By re-engineering the filter
and fiber bundle, the Raman probe could be made as small as -500 j m.
4.1.4 Coupling to the Raman system
The excitation fiber was connectorized with an FC connector and coupled to both the
830 nm and 740 nm laser, in a manner similar to the method described in Section 2.1.1.
To couple the collection fibers into the spectrometer, the proximal tips of the fibers were
arranged in a linear array, epoxied together, polished, and then aligned at the input of the
spectrometer. This geometry maps each fiber to a different vertical position on the CCD
(Figure 4-3). The 100 gm core diameter matches the internal slit of the benchtop Raman
system, yielding a spectral resolution of 8 cm - .
4.1.5 Benchmarks
Probe background
An important metric for evaluating the quality of a Raman probe is based on the magnitude
of the self-generated probe background signal. While the most important component of
the probe background is typically the Raman signal generated within the silica fibers, the
background signal may also arise from other materials within the optical path, such as
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Figure 4-3: The Raman probe was coupled to the spectrometer and illuminated with a neon
lamp. The individual fibers can be seen in the resulting CCD intensity image. Numbers
on the axes are CCD pixel numbers; incoming light is dispersed in wavelength along the
x-axis. The inset shows an expanded view of the fiber alignment.
epoxy and tubing. The shape and magnitude of the probe background can be assessed by
acquiring the Raman spectrum while the probe is held in air, not interrogating any sample.
The background signal for a representative Raman probe is shown in Figure 4-4. First, the
background spectra were acquired with the FP or HW laser on and the catheter held in air.
Then the lasers were blocked and a dark spectrum was acquired in ambient light conditions.
The ambient spectrum was subtracted from each background spectrum, and the resulting
spectrum was smoothed with a Savitzky-Golay filter. This is a best case scenario; when
the probe is illuminating a scattering sample, a higher magnitude background signal may
result.
The FP background spectrum exhibits the classic silica fiber Raman background [113],
with characteristic bands at 300 - 530 cm - 1 , at 603 cm - 1, and at 809 cm-'. The FP
background signal intensity is very low, with a maximum of only 80 counts. The HW
background spectrum has few features. In the HW region of interest (2818 - 3021 cm- 1),
there is a small, broad background signal, with a magnitude of only -10 counts. The small
magnitude of the background signals in both wavenumber regions demonstrates both the
effectiveness of the filter and the good fabrication of this particular probe.
Acetaminophen spectrum
Raman spectra of acetaminophen powder acquired with the probe exhibit all of the expected
peaks without distortion (Figure 4-5). The FP spectrum has a slight silica Raman signal
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Figure 4-4: Raman probe background signal.
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Figure 4-5: Raman probe acetaminophen spectrum.
in the 300 - 600 cm - 1 range.
However, Figure 4-6 shows an example of a poorly fabricated Raman probe. In this
case, the fiber bundle was misregistered with the patterned filter, leaving several of the
collection fibers uncovered by the longpass filter (Figure 4-6(a)). This probe was used to
acquire the Raman spectrum of acetaminophen powder (Figure 4-6(b)). In the improperly
filtered fibers (1, 2, and 3), Raman bands from the silica are clearly visible at 300 - 530
cm - 1 , at 603 cm - 1, and at 809 cm - 1. While not entirely absent, the silica Raman signal is
smaller in fibers 4 and 5, which are properly filtered.
4.2 Raman probe performance with distance
We expect the intracoronary Raman catheter will follow the same imaging paradigm as
intravascular ultrasound, in which a small diameter catheter is placed within the artery.
The catheter is free to move laterally within the lumen, and the distance between the
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Figure 4-6: An improperly filtered Raman probe.
catheter and the arterial wall can vary with time. Because the distance between the Raman
probe optics and the artery directly affects the total Raman signal collection, we explore
the relationship between distance and signal intensity in saline and whole blood.
Using the forward-viewing filtered fiber bundle described in the previous section, we
investigated Raman signal strength as a function of probe-tissue separation distance, with
both saline and blood as intervening media. First, the probe was mounted onto a vertically
oriented translation stage and placed in contact with ex vivo human aorta (z = 0 mm).
A contact Raman spectrum was acquired. The probe was then translated away from the
tissue at fixed steps (Az = 250 gm), and Raman spectra were acquired at each step.
With saline as the intervening medium, the magnitude of the Raman spectrum decreases
as the distance between the probe and the tissue increases, but the spectral features remain
the same (Figure 4-7(a)). The Raman signal strength was quantified by integrating the
spectrum over an arbitrarily chosen band (2910 - 2940 cm-1). The Raman signal strength
decreases to 50% at a distance of approximately 2 mm (Figure 4-7(b)).
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Figure 4-7: Raman probe performance through varying distance of saline. (a) High
wavenumber Raman spectra of ex vivo human aorta in contact (blue) and through 5 mm of
saline (green). The same spectral features are present in both spectra. To evaluate signal
strength, spectral intensities were integrated in the region between the dashed lines. (b)
Raman signal strength as a function of distance through saline.
The same experiment was repeated with porcine blood as the intervening medium be-
tween the probe and the tissue. As the distance through blood increases, the overall Raman
signal intensity decreases. Furthermore, the collected Raman spectrum transitions from
that of the tissue in contact to that of blood alone (Figure 4-8(a)). For distances greater
than 2 mm, the Raman probe measures the Raman spectrum of the blood only, with no
signal being collected from the tissue. Thus the relevant parameter in this case is not the
total signal strength, but the strength of the tissue Raman signal, as opposed to the blood
Raman signal. This was evaluated by fitting each collected Raman spectrum as a linear
combination of two basis spectra: the tissue contact spectrum (z = 0 mm) and the blood
only spectrum (z = 3 mm). Examining the normalized tissue fit coefficient as a function
of distance (Figure 4-8(b)), the tissue Raman signal strength decays to 50% at z = 0.5
mm. For z > 1 mm, the collected Raman spectrum is dominated by blood. Blood is a
non-negligible absorber in the near infrared region [114], so as the probe-tissue separation
distance increases, both the excitation light reaching the tissue and the returning Raman
light are attenuated.
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Figure 4-8: Raman probe performance through varying distance of blood. (a) High
wavenumber Raman spectra of human aorta through varying distances of blood. As the dis-
tance through blood increases, the spectrum morphs from the pure tissue spectrum (z = 0
mm) to the pure blood spectrum (z = 3 mm). (b) Tissue fit coefficient as a function of
distance. For probe-tissue distance greater than 1 mm, the measured Raman spectrum is
predominantly that of blood.
These experiments demonstrate that it is not feasible to conduct Raman spectroscopy
through more than -500 gm of blood using this probe. Thus intracoronary Raman spec-
troscopy requires either a saline flush to remove blood from the artery before imaging, or a
catheter that is designed to maintain contact with the arterial wall.
4.3 Discussion
One of the challenges that has limited the development of small diameter Raman probes
is the need for distinct optical filters for the excitation and collection channels. Previous
researchers have utilized micro-optical machining techniques to create separate filters, which
were then incorporated into Raman probes. However, these filters and the resulting Raman
probes were difficult and time-consuming to fabricate. In this work, we have utilized custom-
made monolithic patterned filters, which greatly simplifies the Raman probe fabrication
steps. Using a self-assembling fiber bundle and a patterned monolithic filter module, our
Raman probe is 775 jm in diameter, though it can be re-rengineered to be as small as 500
gm without losing signal collection area.
Since the Raman probe will be incorporated into a catheter that can move freely within
the arterial lumen, it is important to understand how the signal changes as a function of
distance to the arterial wall. We experimentally investigated this, using both saline and
porcine blood as the intervening medium. In saline, as the probe-tissue distance increases,
the magnitude of the collected Raman signal decreases. The spectral signature of the
acquired Raman spectrum remains constant for all distances.
However, in blood, the collected Raman spectrum has contributions from both the tissue
and the blood, and for distances greater than -1 mm, the Raman probe collects only the
blood Raman spectrum. This is explained by the fact that the excitation light is attenuated
before it reaches the tissue, resulting in a small tissue Raman signal that is also attenuated as
it propagates to the collection fibers. Thus performing intracoronary Raman spectroscopy
through blood over distances greater than -0.5 mm is not feasible. There are two possible
solutions; one is to design a catheter than can maintain contact with the arterial wall. The
other, clinically preferred approach is to use a saline purge during imaging to evacuate the
blood.
Using a forward-viewing contact Raman probe, Motz et al. have demonstrated that
incorporating a lens at the distal end of the filtered fiber bundle can increase the magnitude
of the collected Raman signal [86]. However, an intracoronary catheter may have variable
probe-tissue separation distance, and the effectiveness of a distal lens is likely to vary with
the distance between the probe and the tissue surface. Experimentally exploring the lens
parameter space is cumbersome and cost-ineffective, so in Chapter 6 we develop a simulation
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technique that can be used to computationally simulate Raman probe performance and thus
aid in comparing probe designs.
4.4 Conclusion
In this chapter, we have demonstrated a simple Raman probe incorporating a self-assembling
fiber bundle and shortpass and longpass filters patterned on a monolithic substrate. Ulti-
mately the Raman probe will be incorporated into a catheter that will be able to freely move
within the arterial lumen; thus the probe will be at variable distances from the arterial wall.
Thus we investigated the probe's signal collection as a function of probe-tissue separation
distance, through saline and blood. With blood as the intervening medium, the collected
Raman spectrum is dominated by blood after a distance of -1 mm, suggesting a fundamen-
tal limitation that precludes conducting intracoronary Raman spectroscopy through blood.
In saline, as the distance between the probe and the tissue surface increases, the Raman
signal magnitude decreases, and spectral features are retained.
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Chapter 5
Raman Catheter in a Xenograft
Model
In this chapter we describe the conversion of the Raman probe in Chapter 4 into a side-
viewing Raman catheter. The performance of the prototype Raman catheter was tested in
vivo in a human-swine xenograft model, in which human coronary arteries obtained from
cadaver are grafted onto a living swine.
5.1 Raman catheter
The Raman catheter is based on the forward-viewing Raman probe described in Chapter
4, consisting of a 6-around-1 fiber bundle bonded to a patterned filter module. The fiber
bundle was converted into a side-viewing Raman catheter by incorporating a 450 mirror and
placing the entire assembly into an appropriate outer sheath, using off-the-shelf components
(Figure 5-1).
To hold the bundle and mirror in place, a window was cut in a 1.5 mm outer diameter
stainless steel tube. The filtered fiber bundle and a 450 aluminum-coated rod mirror (NT47-
628, Edmund Optics; Barrington, NJ) were epoxied into the tube, taking care not to allow
any epoxy to leak between the filter and the mirror. A 1.5 m nylon sheath was bonded to the
proximal end of the steel tube to house the loose optical fibers. A second, 2 cm nylon sheath
was bonded to the distal end of the tube and modified to provide a rapid-exchange guide
wire port. Clear medical grade heat shrink tubing was used to seal the assembly. When
the catheter was held in contact with a sample, the laser spot size was approximately 1 mm
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in diameter. Estimated from Monte Carlo simulations, we believe the catheter's sampling
volume in arterial tissue was approximately 1 mm3 , when the catheter was in contact with
the arterial surface.
The materials and geometry of the side-viewing catheter lead to a more intense and
more feature-rich background signal than the forward-viewing filtered fiber bundle (Figure
5-2). The FP background spectrum is dominated by silica bands, but it also has strong
bands at 855, 1288, 1614, and 1725 cm - 1 , arising from the heat shrink tubing. This is one of
the challenges for FP Raman probes; despite the fact that the heat shrink tubing thickness
is only - 25 gm, it still contributes appreciably to the catheter background spectrum in the
region of interest. The heat shrink also contributes a band in the HW region at 3083 cm-1,
but this is fortunately outside the Raman shift region of interest. The catheter background
spectrum is much larger in magnitude than that of the forward-viewing Raman probe.
This is probably due to two geometry related effects: 1) the addition of the mirror and
stainless steel tube may cause strong reflections to go back into the catheter and increase
the background, and 2) there may be variability in the catheter fabrication process.
5.2 Xenograft procedure
5.2.1 The xenograft model
The prototype Raman catheter was tested in a human-swine xenograft model, in which a
diseased human coronary is harvested from a cadaver, sutured on top of a living swine's
heart to simulate cardiac motion, and connected to the swine's arterial circulation to provide
physiologic blood flow conditions [115]. Following grafting, an intracoronary device can then
be advanced through the grafted human artery. The human-swine xenograft accurately
models the blood flow, motion, and compression and expansion of native coronary arteries,
which enables testing of intracoronary devices for diagnosing real human pathology in an
environment closely resembling human coronary physiology.
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Figure 5-1: First generation Raman catheter. The Raman
fiber bundle and a 45' mirror enclosed in an outer sheath.
the mirror were epoxied into a steel tube (1.5 mm diameter).
fibers at the fiber/filter interface is reflected by the mirror.
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Figure 5-2: Raman catheter backgrounds as measured in air. The Raman catheter has
background signals arising from silica and the other catheter materials.
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Surgical procedure
Coronary arteries were harvested from an adult cadaver heart.1 Segments of the coronary
artery were prosected en bloc with surrounding muscle and epicardial fat to preserve archi-
tecture. The major side branches were ligated to prevent leakage and standard Luer lock
connectors were attached to each end of the arterial segment. The grafts were preserved in
cold saline until implantation.
At the start of the procedure, a female Yorkshire swine weighing approximately 40 kg
was anesthetized, intubated, and ventilated with maintenance anesthesia of isofluorane.
Heart rate and rhythm, temperature, and oxygen saturation were continuously monitored
throughout the procedure. In accordance with the standard of care for catheterization
procedures, heparin was administered to the swine to prevent the formation of blood clots.
The animal's heart was surgically exposed, and the proximal end of the cadaver artery
was grafted to the animal's carotid artery via a cannula. The distal end of the cadaver
artery was then grafted to the animal's femoral artery through another cannula. This
procedure established blood flow from the swine's carotid artery, through the first cannula,
and into the grafted artery. Blood was then returned to the swine's circulation via the
second cannula to the femoral artery.
After the graft was in place, the side-viewing Raman catheter was introduced through
the proximal cannula and spectra were taken at two distinct sites of the grafted artery. At
the end of the experiment, the animal was euthanized. The human coronary artery segment
was harvested, fixed in formalin, and sent for histological processing.
5.2.2 Data acquisition
Raman spectra were acquired from the grafted human artery in vivo, using illumination
powers of 100 mW at 830 nm and 85 mW at 740 nm. FP and HW spectra were acquired
over 40 frames at 0.25 s each for a total acquisition time of 10 s at each site, enabling
us to evaluate spectral quality as a function of integration time. Based on previously
reported results [83, 87] and ex vivo experiments performed in our laboratory [116], we
believe that these laser fluences do not cause arterial tissue damage or blood coagulation.
After each Raman measurement, the interrogated site (identified by visualizing laser light
1The xenograft procedure was performed at the Tufts-New England Medical Center, under approval from
the Institutional Animal Care and Use Committee (Protocol #55-06).
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transmitted through the artery wall) was marked with green ink for subsequent correlation
with histology.
5.3 Results
Raman spectra were extracted from the raw spectra using established post-processing meth-
ods. First, a specified number of raw data frames were averaged together and divided by the
white light reference spectrum. The tissue fluorescence spectrum was removed by subtract-
ing a fifth (FP) or sixth (HW) order polynomial, and the catheter background was removed
by subtracting a processed background spectrum, scaled to remove the bands resulting from
the heat shrink tubing (1614 cm - 1 and 3083 cm-1). To determine the minimum necessary
acquisition time, we averaged various numbers of frames together and analyzed the result-
ing processed Raman spectra. The Raman spectra shown in Figure 5-3 correspond to an
integration time of 4 s (16 frames).
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Figure 5-3: Raman spectra obtained in a human artery grafted to the beating heart of a
living swine. Spectra were processed from 16 averaged frames, representing a total acquisi-
tion time of 4 s. (a) FP and (b) HW spectra obtained at site 1, with (c) corresponding H&E
histology. (d) FP and (e) HW spectra obtained at site 2, with (f) corresponding Oil-red-O
histology. Black arrows denote brown-orange staining of lipid in the direction of the spectral
measurement and dark blue staining of a large calcific nodule nearby. Red arrows in (c) and(f) denote spectral measurement locations and directions. Calc. is calcium hydroxyapatite.
Scale bars, 0.5 mm.
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Raman spectra from the two sites differ significantly. In site 1 (Figures 5-3(a) and 5-
3(b)), the FP Raman spectrum contains a prominent peak at 960 cm - 1 (corresponding to
the phosphate stretch of calcium hydroxyapatite) and minimal lipid. The Raman spectrum
is consistent with histology, which demonstrates a large calcific nodule (Figure 5-3(c)).
Spectra obtained at the second site (Figures 5-3(d) and 5-3(e)) show peaks representative
of adventitial triglycerides (CH 2 bends at 1301 and 1440 cm - 1 and C=C stretch at 1654
cm - 1 in the FP spectrum and -2836 cm - 1 in the HW spectrum). There is an increased
contribution from cholesterol (-2870 cm - 1) in the HW spectrum, which may correspond
to a small amount of lipid staining seen on the Oil-red-O histology section (Figure 5-3(f)).
A minute calcium hydroxyapatite signal is also present, which may result from the large,
adjacent calcific nodule.
5.4 Discussion
In this chapter, we have demonstrated a catheterized version of the Raman probe described
in Chapter 4, capable of acquiring both FP and HW Raman spectra in vivo. This catheter
exhibits a higher magnitude, more feature-rich background spectrum than the forward-
viewing Raman probe, arising from the extra materials associated with the catheter. In
particular, in the FP region, the heat shrink tubing used to seal the catheter optics has a
Raman spectrum with sharp peaks that overlap with the tissue Raman signal. The heat
shrink tubing's added band in the HW region does not overlap with the tissue Raman signal.
While the catheter background can be mitigated by carefully choosing catheter materials,
the relative paucity of bands in the HW region highlights a strong advantage of the HW
region over the FP region for conducting catheter-based Raman spectroscopy.
The present catheter has a relatively large outer diameter of 1.5 mm (4.5 Fr), due to
the use of the 1 mm diameter off-the-shelf mirror. The catheter's size-limiting factor is
the 775 gm diameter of the fiber bundle and filter. Thus the overall catheter diameter
can be reduced to less than 1 mm by simply replacing the side-viewing mirror and outer
sheath, which will bring the catheter diameter on par with that of commercially available
intracoronary imaging catheters.
The catheter was tested in vivo in a xenograft procedure, a model developed for testing
intracoronary devices on human pathology in an environment that is physiologically similar
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to humans. Spectral differences were seen between a calcified site and a lipid-rich site in
both the FP and HW regions.
The present catheter has not been optimized for optical design, and thus it operates in a
relatively low SNR regime. The xenograft results demonstrate several advantages to the HW
region. First, the signal in the HW region is -6 times higher than in the FP region, resulting
in higher SNR. Second, as mentioned, catheter design in the FP region is more difficult
because many polymer materials that might be incorporated into the catheter contribute a
large Raman and/or fluorescent background signal. Fewer materials have a Raman signal
that overlaps with the HW region of interest, so HW catheter design may be simpler.
Indeed, a HW catheter may not need optical filters at all [88]. Finally, the lack of a strong
background signal in the HW region also simplifies the data processing, since subtraction
of an overlapping background spectrum is not required. These advantages suggest that
the HW region is preferred over the FP region for catheter-based Raman spectroscopy, but
these considerations must be balanced against the lower information content available in
the HW region.
The SNR of the collected Raman spectra can be improved by optimizing the catheter.
Because of the side-viewing geometry, even when the catheter is held in contact with the
tissue, the probe-tissue separation distance, as defined in Chapter 4, is approximately 1
mm in air. Thus the signal intensity for the Raman catheter is relatively low compared to
the forward-viewing Raman probe. The catheter optical geometry can be optimized signifi-
cantly. For example, simply decreasing the outer diameter of the catheter would decrease the
probe-tissue separation distance and result in increased signal. The 450 aluminum-coated
mirror could be replaced with a gold or silver mirror to increase reflectivity. Furthermore,
the 450 mirror and resulting air gap could be entirely replaced by a mirror-coated prism,
which would be better index-matched to the filter and thus maintain a smaller excitation
spot size. The optical simulation technique in Chapter 6 may be a useful tool for exploring
these and other alternative designs.
5.5 Conclusions
In this chapter, we have converted the foward-viewing Raman probe into a side-viewing
Raman catheter and demonstrated it in in vivo in a xenograft model. Spectral differences
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were seen between the two interrogated sites in the grafted artery. For catheter-based
Raman spectroscopy, the HW region has several advantages over the FP region, including
potentially simpler probe design, simpler data processing, and higher overall signal. Future
work should concentrate on increasing the Raman signal SNR through optimization of the
catheter optics.
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Chapter 6
Optical Modeling for Catheter
Design
The success of an intracoronary Raman catheter depends on its ability to acquire spectral
data with sufficiently high signal-to-noise ratio for accurate spectral analysis. Furthermore,
the SNR must remain high throughout the catheter's expected operating conditions, i.e.,
throughout the range of expected catheter-tissue distances. While we have demonstrated a
catheter without a lens in Chapters 4 and 5, questions remain about whether or not a lens at
the distal tip would increase Raman collection efficiency. Since experimental optimization
of the probe design is costly and time-consuming, we have chosen to develop a model-based
approach that in the future will enable optimization of Raman catheter designs.
In this chapter, we describe a optical simulation technique that enables assessment of
sampling volume and collection efficiency for a given Raman probe design, prior to fab-
ricating and experimentally characterizing the probe. This optical simulation technique
accounts for 1) the propagation of excitation laser light through the excitation fiber and
into the sample, 2) the resulting generation of Raman light within the sample, and 3) the
subsequent propagation of Raman scattered light through the sample and into the probe's
collection optics. The simulation technique combines several existing software tools, namely
a freely-available Monte Carlo software package for propagation through tissue, and a com-
mercial package for modeling light propagation through the probe's optical components.
In this chapter we describe the simulation technique and present experimental validation
results.
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6.1 Monte Carlo Modeling
Light propagation in biological tissue is a diffusive process in which each photon takes a
random walk through the tissue. For turbid media, analytical solutions to the radiative
transport equation exist only for simple geometries, so Monte Carlo simulations are often
used as a numerical tool to simulate light transport in tissue. In this section, we provide
an overview of the Monte Carlo model, a mathematical basis for incorporating Raman
scattering into the Monte Carlo model, and a convolution method for reducing computation
time.
6.1.1 Standard Monte Carlo Model
Monte Carlo simulations are commonly used to model light propagation in tissue [117].
In Monte Carlo simulations, light propagation is modeled by stochastically tracing the
propagation paths of a large number of photons (typically > 105), to converge on the
real profile of interest. The basic procedure for a fixed weight, variable step-size Monte
Carlo simulation is shown in Figure 6-1. First, a photon is initialized with its position and
propagation direction determined by the desired simulation geometry. At each step, the
photon is moved a random distance As in the tissue, where it can be scattered, absorbed,
internally reflected, or transmitted out of the tissue. In a fixed-weight Monte Carlo model,
when a photon is absorbed, propagation stops, and the photon's absorption position is
recorded. If a photon is elastically scattered or internally reflected, a new step size and
random propagation direction are determined, and the photon continues to propagate until
it is either absorbed or remitted from the tissue. This basic process is repeated until the
desired number of photons have been propagated. The optical properties of the tissue
determine the propagation distance and angle at each step, as described in further detail
below.
The simulation geometry is typically defined with the z axis positive going into the tissue
(Figure 6-2(a)). Each photon is described by its position (x, y, z), its propagation direction,
expressed by direction cosines (px, p, , z), and its weight, w. The direction cosines are
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Figure 6-1: Block diagram of the basic Monte Carlo simulation method.
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related to propagation angle (Figure 6-2(b)) by
px = sin() cos(0)
py = sin() sin(0) (6.1)
, = cos(C).
For example, in a collimated pencil beam, the standard for Monte Carlo simulations, all
photons are launched from the same initial position (0, 0, 0), with all photons directed
vertically downward into the tissue (Px = 0, ay = 0, L, = 1).
ey
(a) (b)
Figure 6-2: Monte Carlo simulation geometry. (a) Coordinate axes for tissue, with positive
z indicating depth. (b) A photon's propagation direction is defined by 4, its deflection angle
from a reference axis, and 0, its azimuthal angle about that axis.
In the photon model of propagation through a turbid medium [117], the probability of
a photon propagating through a distance 1 of tissue without being absorbed is modeled as
an exponential process:
pa(I) = Ma exp(-pal), (6.2)
where ia is the absorption coefficient. Similarly the probability of the photon propagating
through a distance 1 before being scattered is
ps(1) = ps exp(-pl.), (6.3)
where p, is the scattering coefficient. In the standard Monte Carlo method, the two expo-
nential processes describing absorption and scattering are merged to determine the proba-
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bility of a photon traveling a distance 1 with no interaction:
pt(1) = pIt exp(- Itl), (6.4)
with
P t = Pla + LPs. (6.5)
This probability density function (pdf) is used to generate the step size, As = 1, for each
iteration of the Monte Carlo simulation; the step size is interpreted as the distance the
photon travels before a scattering or absorption event occurs. After the photon has been
propagated through the distance As, the exponential pdfpt (1) is split to yield the probability
that the photon is absorbed,
Pr(photon is absorbedlan event occurred) = Pa (6.6)[t
and the probability that the photon is scattered,
Pr(photon is scatteredlan event occurred) = = albedo. (6.7)[t
To decide whether the photon is absorbed or scattered, a uniformly distributed random
number, (, is generated, and if ( < , the photon is absorbed, otherwise it is scattered.
For scattered photons, a new propagation direction is determined, requiring two new
angles. The deflection angle, 0, defined with respect to the photon's current propagation
direction, is stochastically determined by a scattering phase function, commonly the Henyey-
Greenstein phase function [118],
1 - g2Pr(cos ) = 2gcos¢) 3/2 ,with ¢ E (0, 7), (6.8)
2(1 + g2 - 2g cos )3/
where g is the anisotropy parameter, defined as g = E[cos 0]. The azimuthal angle is taken
to be uniform, 0 E [0, 27].
In practice, the fixed weight Monte Carlo is rarely used, due to the long computation
required to reach convergence. Instead, a weighted Monte Carlo model is used, where
instead of propagating individual photons, photon packets, or groups of photons that travel
together, are propagated. At each step, a portion of the photons are absorbed (t), so the
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corresponding weight is dropped from the photon packet. The remaining photons in the
packet continue to propagate as usual.
Monte Carlo simulation requires the propagation of a large number of photons to ensure
statistical convergence of the results. The required number of photons depends on the
geometry and the optical properties used in the simulation, but is typically on the order of
105 photons for biological tissue.
Typical outputs of a standard Monte Carlo simulation include the 3D absorption profile
in the tissue, A(x, y, z), and the 2D distribution of photons remitted from the surfaces of
the tissue E(x', y', 5, 0), i.e., remitted flux and exit angle as a function of x' and y' on the
tissue surface.
6.1.2 Incorporating Raman scattering into the Monte Carlo model
Previous researchers have added fluorescence to the Monte Carlo model by assuming that
the absorbed photons will either be converted to heat or re-emitted as a fluorescent pho-
ton [119]. Similarly, Raman scattering may be modeled by assuming that all scattered
photons will either be elastically scattered or inelastically scattered, the latter generating
a Raman photon [120]. Each Raman photon is assumed to be isotropically generated, i.e.,
the photon's initial phase and direction are uniformly distributed.
Raman scattering can be considered analogously to Eq. (6.2) and (6.3). The probability
of a photon traveling through a distance 1 before being Raman scattered can be expressed
as
PR(1) = pRexp(-pRl), (6.9)
where pR is the Raman scattering coefficient. Absorption, scattering, and Raman scattering
can again be merged to determine the probability of a photon traveling a distance 1 with
no interaction:
Pt,(1) = Pt, exp(-ptl), (6.10)
with
At' = PR + Oa + Ps, (6.11)
where At' now includes Raman scattering.
Directly using this model to simulate Raman scattering requires the propagation of
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a very large number of photons (> 1014 photons), because only a small percentage (~1
in 1010) of all incident photons are Raman scattered. This simulation is computationally
intensive.
Alternatively, since both absorption and Raman scattering are modeled as events that
"destroy" the propagating photon, the two processes can be merged into a "destruction"
event, by lumping the two parameters:
PD = [a + AR. (6.12)
Equation (6.11) can be rewritten as
t' = PD + Ps. (6.13)
Since Raman scattering is a very low probability event, AR < Pa, and thus pt' - t
and ILD 4 C Pa. Thus, Raman scattering can be simulated using the standard Monte Carlo
model, where photon absorption is now treated as photon destruction. After propagating
a photon using the standard model, the photon destruction process can then be split into
absorption and Raman scattering events, with
Pr(photon is absorbed destruction event occurred) = - a Pa (6.14)
PD Pa + AR
and
Pr(photon is Raman scattered destruction event occurred) = R R . (6.15)
AD Pa -+ -R
The spatial distribution of Raman scattering events differs from the spatial distribution of
absorption events by a constant factor, PR/Pa. Thus, it is possible to efficiently simulate the
generation of Raman scattered photons using the standard Monte Carlo model and scaling
the resulting absorption profile appropriately.
One method for simulating the spatial distribution of remitted Raman scattered light
might involve propagating a photon until it is absorbed by the medium, and then storing its
absorption position as the generation position for a new Raman photon. Once the location
of all Raman scattering events has been determined, the distribution of remitted Raman
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photons can be evaluated by performing a separate, simplified Monte Carlo simulation,
using optical property values appropriate for each Raman photon's wavelength. The sim-
plified simulation utilizes the basic Monte Carlo model described in Section 6.1.1, in which
only elastic scattering or absorption may occur. The initial position of each photon is the
absorption location recorded above, and the new direction is isotropically generated (both 0
and 0 are uniform with q E [0, 7r] and 0 E [0, 2r]). The weight of the photon packet remains
unchanged. Throughout the simulation, the locations of all absorbed and remitted Raman
photons are recorded.
This simulation is still computationally intensive. Fortunately, the Raman Monte Carlo
model can be simplified to enhance computational efficiency by incorporating a convolution
model, which has been previously demonstrated for simulations of fluorescent photons [121].
6.1.3 Convolution model for efficient Raman Monte Carlo simulations
For computational efficiency, a convolution model can be used to determine the absorption
and emission profiles for the Raman scattered light. In this model, two effects are simulated
separately: 1) the propagation of excitation photons and resulting isotropic emission of
Raman photons, and 2) the propagation of the newly generated Raman photons. Results
from each simulation step are then combined through convolution.
In the first step, a "Raman source," ERaman,gen(X, y, z), is simulated, representing the
probability of a Raman photon being scattered at position (x, y, z) within the tissue. This
source can be efficiently simulated by assuming that the spatial distribution of Raman scat-
tered photons is a scaled version of the distribution of absorbed photons, as described in the
previous section. A standard Monte Carlo simulation is run for the excitation wavelength,
keeping track of absorbed photons, without propagating new Raman photons.
Next, we simulate the propagation of generated Raman photons. We consider a Raman
point source, located at position (x, y, z). We assume that the remitted light distribution
from each Raman point source is spatially invariant in x and y, i.e., the distribution de-
pends only on the depth, z, from which the photons originate and not the point source's
(x, y) position. This assumption is valid when the tissue is modeled as a series of homoge-
neous semi-infinite layers. Thus for each depth zo of interest, one simulation is performed,
consisting of an isotropically emitting point source located at (x = 0, y = 0, z = zo). This
yields the Raman emission profile, Eiso,em(X', y'; x = 0, y = 0, z = zo), where x' and y' are
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coordinates on the tissue surface, and (x = 0, y = 0, z = zo) is the location of the isotropic
emitter.
Finally, for each depth of interest (zo E [Zmin, Zmax]), the corresponding Raman source
ERaman,gen(X, Y, Z = ZO), is convolved with Eiso,em(X', y'; x = 0, y = 0, z = zo) to determine
the total remitted Raman light from that depth. To determine the total Raman emission
profile, using superposition, the responses from each depth can be integrated:
ERaman,emitted(X', Y') = (ERaman,gen (x, y, zo) * Eiso,em (x', y'; 0,, zo)) dzo. (6.16)
The output of this procedure, ERaman,emitted(X I, y'), represents the spatial distribution
of the flux of the remitted Raman light. The distribution of exit angles of the remitted
Raman photons can be calculated analogously.
6.2 Simulating Sampling Volume
Using the Raman Monte Carlo model described in Section 6.1, we can determine the Ra-
man sampling volume of an optical system. Consider a probe in contact with tissue (Fig-
ure 6-3(a)), which may consist of a ring of collection fibers surrounding a central excita-
tion fiber, as in Chapter 4. For a given optical geometry, we evaluate the percentage of
ERaman,emitted(X', y'; x, y, Z) that can propagate through the collection optics and ultimately
be detected by the spectrometer's CCD.
Keeping track of this quantity on a voxel-by-voxel basis yields the sampling volume. We
define a new quantity, ERaman,coll(X y, z), as the percentage of Eiso,em(X', y; x, y, zo) that is
collected. Then we define
ERaman,sampling volume(x, Y, z) = ERaman,gen(x, y, z) x ERaman,coll(X, y, z). (6.17)
This quantity represents the total collected Raman signal originating from the voxel centered
at (x, y, z), and it accounts for both the excitation geometry and collection geometry of the
Raman probe. By summing and properly scaling these results, we can also define the Raman
probe's collection efficiency.
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6.2.1 Implementation
For practical reasons, we use two separate software packages to simulate the Raman probe
sampling volume (Figure 6-3). For propagating photons through tissue, we use a freely
available software package released by Lihong Wang and Steven Jacques, Monte Carlo
for Multi-Layered media (MCML)1 [122], which we have modified for this purpose. To
propagate through the optical elements of the catheter, we use a commercially available
ray tracing program, Zemax (Zemax Development Corporation; Bellevue, WA). Finally,
we use MATLAB (The MathWorks; Natick, MA) to convert data between the preferred
input/output formats for each software package and to compile the final results.
The general simulation procedure is as follows (Figure 6-3(b)):
1. Propagate excitation light to the interface plane. Zemax is used to propagate
light from the laser source, through the excitation fiber and filter, through any distal
optics in the probe, and finally to the interface plane in Figure 6-3. For all rays that
hit the interface plane, the ray's position (x, y, z), direction cosines (px, Iy, pz), and
weight, w, are recorded and stored in a file.
2. Propagate excitation light from the interface plane and into the tissue to
determine ERaman,gen(X, y, z). The stored excitation rays at the interface plane are
then propagated through the tissue using our modified MCML. Absorption is recorded
for each voxel, yielding the Raman source ERaman,gen(X, y, z).
3. Propagate isotropically emitted Raman photons to the interface plane to
determine Eiso,em (X, y'; 0, 0, zo). Independent of the first two steps, which are re-
lated to the excitation only, we perform the Raman emission simulations. For each
depth of interest, we create a Raman point source, i.e., we generate isotropic Raman
photons in a voxel centered at (x = 0, y = 0, z = z 0o). The modified MCML is used
to propagate the isotropically genererated photons through the sample, using opti-
cal properties appropriate for the Raman photons' wavelength. For all rays exiting
the interface plane towards the catheter, the exit position (x', y'), direction cosines
(px, Py, JPz), and weight, w is recorded. This yields Eiso,em(X', y'; 0, 0, z 0 ).
1The source code and its extensive documentation can be downloaded from
http://omlc.ogi.edu/software/mc/.
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Raman
Probe
z
Tissue
Zemax: propagation through all
optical elements
MATLAB: computations at interface
between Zemax and MCML
MCML: propagation in the tissue
(a) Software packages
Set up geometry (Zemax and MCML)
Propagate excitation Propagate Raman
light through optics emission in tissue
Convert Convert
Propagate excitation Propagate Raman
light in tissue light through optics
SMultiply L
Calculate metrics of interest
(sampling volume, collection efficiency)
(b) Simulation procedure
Figure 6-3: Combined Monte Carlo/Zemax optical modeling. Zemax is used to propagate
photons through the optical elements of the probe, and MCML is used to propagate pho-
tons through the tissue. MATLAB is used to convert inputs/outputs of both programs as
necessary at the interface plane between the probe and the tissue.
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4. Propagate Raman photons from the interface plane and through the probe
to determine ERaman,coll(X, y, z). For each voxel in the sample, we wish to deter-
mine the percentage of generated Raman photons that can propagate through the
probe to the spectrometer. To accomplish this, the recorded exiting Raman rays from
step 3 are shifted by the center coordinates of the voxel, and Zemax is used to deter-
mine the appropriate percentage. In other words, to calculate ERaman,co(X ll Xl, =
yi, z), we shift the distribution Eiso,em(', y'; 0, 0, zo) by (x 1 , yi) to get Eiso,em(X' +
x 1, y' + yi; x1, yi, zo), and then propagate this distribution in Zemax. Thus, a sep-
arate Zemax calculation is performed for each voxel. The output of this step is
ERaman,coll(X, Y, z), a 3D matrix in which the value of each voxel represents the col-
lection efficiency for Raman photons generated in that voxel.
5. Multiply to determine the sampling volume, ERaman,sampling volume(x, Y, Z).
Finally, we use MATLAB to calculate the Raman sampling volume according to Eq.
(6.17). This 3D matrix represents the relative Raman intensity that is collected from
each voxel. The probe's collection efficiency can also be calculated from this matrix.
It is important to note that the physical interpretation of the numerical values of
ERaman,sampling volume(X, Y, z) hinges upon accurate knowledge of pR, which is difficult
to measure and generally not known for tissue. Nevertheless, these numerical values
can be used to compare simulation results from one probe geometry to another and
thus compare the relative performance of various probe designs.
6.2.2 Monte Carlo for Multi-Layered media (MCML)
By default, MCML is programmed to propagate a pencil beam into the tissue and to record
absorption in the tissue, reflectance from the tissue, and transmission through the tissue,
on a cylindrical grid. We have incorporated several modifications to MCML to make it
suitable for modeling Raman sampling volume. First, we modified MCML to initialize
photons with arbitrary initial position, direction, and weight. MCML was modified to read,
from an accompanying input file, seven parameters for each ray: position (x, y, z), direction
(~x, py, z), and photon weight, w. Second, MCML was modified to record the same seven
parameters for each ray exiting the tissue; this output file is later converted to an input file
for Zemax. Finally, we added a dynamically allocated 3D matrix to keep track of absorption
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in the tissue as a function of (x, y, z).
6.2.3 Zemax
We used Zemax in non-sequential mode, which allows for ray tracing. To propagate the
excitation light through the probe, a Zemax source is defined at the proximal end of the
excitation fiber, to model the output of the laser source. A detector is placed at the distal
surface of the probe (the interface plane) to record the rays that cross the interface plane;
these rays are saved as a Zemax source file and later converted to an MCML input file.
To propagate the remitted Raman light from the interface plane and thus calculate
Raman collection, a source file is defined at the interface plane, and detectors are defined
at the proximal end of the collection fibers. The source file contains the MCML output
rays from the isotropic emitter simulations. Rays from the source file are propagated back
through the probe, and the total flux hitting each collection fiber detector is recorded as
the collected Raman signal.
In the Zemax model, we only model the propagation through the first 4 mm of fiber,
explicitly assuming that all rays that meet the fiber's propagation conditions will eventually
propagate through the spectrometer to the CCD. Thus, our current model does not account
for losses in the fiber, especially due to bending, coupling efficiency between the fiber and
the spectrometer, losses in the spectrometer, or the quantum efficiency of the CCD.
6.2.4 MATLAB
MATLAB is used to perform computations at the interface plane between MCML and Ze-
max, mainly consisting of translating ray information from the modified MCML input/out-
put file format to and from the Zemax input/output file format. The MATLAB wrapper
code also converts the position units from MCML's cm units to Zemax's default mm units.
Finally, MATLAB is used in step 5 to calculate the sampling volume and to visualize the
results.
6.3 Validation
In this section we describe experimental validation of the probe sampling volume simula-
tions. One method of measuring Raman probe sampling volume is to sweep a Raman point
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source through the sampling volume and measure the resulting Raman signal as a function
of position. In lieu of a true point source, we have utilized a small diamond chip immersed
in a scattering phantom solution [94]. The diamond is ideal for this purpose because it has
a strong and distinct Raman scattering signal (Figure 6-4). In this section, we describe the
experiment and the details of the corresponding simulation.
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Figure 6-4: Raman spectrum of single crystal diamond, exhibiting a strong peak at 1332
cm - 1
6.3.1 Experimental setup
The general experimental setup is shown in Figure 6-5. A small cylindrical container was
modified to have a microscope cover glass as a side wall, and the container was filled with
a scattering phantom solution with known optical properties. A dual fiber Raman probe,
consisting of a single excitation fiber and a single collection fiber, was placed external to
the container and against the cover glass. A small diamond chip, mounted on the tip of a
hypodermic needle, was submerged in the solution. The diamond chip was scanned through
the sampling volume of the probe, with Raman spectra acquired at every 20 gm within the
volume.
Phantom
The phantom solution was an aqueous mixture of polystyrene microspheres and ink. The
scattering coefficient was controlled via the concentration of 1 gm diameter polystyrene
microspheres (Duke Scientific 5100A, Thermo Fisher Scientific; Waltham, MA). The ab-
sorption coefficient was modified by adding india ink to the solution.
The container holding the phantom solution was a modified centrifuge tube (Corning).
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Figure 6-5: Sampling volume experiment schematic. A small diamond chip mounted on a
needle was immersed in a scattering solution and translated through the sampling volume
of a two fiber Raman probe.
The capped tube was turned upside, and the top was cut off to form a flat-bottom cup.
A notch was cut into the side of the cup and replaced with a cover glass (Fisherbrand
Premium, Thermo Fisher Scientific), which was bonded with epoxy and then sealed with
silicone to prevent leakage. The wall thickness of the cover glass was measured to be 150
lam.
To keep the phantom solution suspended during the experiments, a stir bar was placed in
the bottom of the container, and the container was mounted on a magnetic stir plate (MS-7,
Tri-R Instrument, Inc.; Rockville Centre, New York). The stir plate was then mounted on a
tilt/rotation stage (485, Newport; Irvine, CA), which was used to align the container with
the diamond scan axes.
The optical properties of the phantom solution were chosen to mimic human arterial
tissue. A concise meta-analysis of the published optical property measurements for aorta 2
shows that optical property data is sparse in our wavelength region (800 - 1000 nm). Ex-
trapolating from the published values, -La 1 cm - 1, ps - 100 - 300 cm-1 , and g - 0.9.
Based on these values, we created two phantom solutions, with the optical properties shown
2 "Optical Properties of Aorta," by Steven Jacques, Oregon Medical Laser Center,
http://omlc.ogi.edu/spectra/aorta/index.html
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in Table 6.1. Optical properties are given at two wavelengths: 830 nm, the excitation wave-
length, and 930 nm, which corresponds to the diamond Raman shift at 1332 cm - 1. The
only difference between the two sets of optical properties, which we term "property set A"
and "property set B," is that A has ,s = 200 cm - 1 , which is twice the value of B (is = 100
cm- 1 ).
Table 6.1: Optical properties used in the sampling volume experiments. Two sets of optical
properties were used in the sampling volume experiments; set A and B differ by a factor of
2 in the scattering coefficient. Properties are given for the excitation wavelength, 830 nm
and the diamond Raman signal wavelength, 930 nm, which corresponds to a Raman shift
of 1332 cm - 1.
Set wavelength [nm] Aps [cm - 1 ] pa [cm- 1] g n
A 830 200 1 0.9 1.33
A 930 160 1 0.88 1.33
B 830 100 1 0.9 1.33
B 930 80 1 0.88 1.33
Probe geometry
For the purpose of comparing simulated and experimental sampling volume, we used a sim-
plified Raman probe design to reduce potential discrepancies between the experimental and
simulation geometries. The probe consisted of only two optical fibers, a single-mode fiber
for excitation and a multimode fiber for collection. While the Raman probes of Chapters
4 and 5 used identical multimode fibers for both excitation and collection, the simulation
requires precise knowledge of the excitation beam geometry. Modeling multimode fiber
propagation is nontrivial, especially given the short length of fiber (-2 m) used in a typical
Raman probe and the poorly characterized beam properties of the diode laser source. Thus,
to enable comparison of the experimental and simulation results, we used a single-mode ex-
citation fiber (SM800-5.6-125, Fibercore Ltd; Southampton, UK), which has a well-defined
Gaussian beam output, with a mode field diameter of 5.6 tm. The collection fiber was
identical to the fiber used in the previously decribed Raman probes (100 Im core diameter,
0.26 NA).
Both fibers were bonded to the filter using UV curing epoxy (Norland 61, Norland
Products; Cranbury, New Jersey). The distance between the two fibers was approximately
250 jim, and the collection fiber face was offset from the filter surface by -50 jm.
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The excitation source was a Ti:sapphire laser (Tsunami, Spectra-Physics; Mountain
View, CA) tuned to 830 nm in cw mode. The laser output was bandpass filtered at 830 nm
and then coupled into the single-mode excitation fiber. The collection fiber was directly
coupled to the spectrometer. Fianlly, the probe was mounted on a 3-axis kinematic mount,
which in turn was mounted on a 3-axis translation stage, giving enough degrees of freedom
to align the probe surface with the cover glass.
Diamond
The diamond chip used in these experiments was specifically chosen for its regular shape
(Figure 6-6). The chip was approximately a parellelpiped, with dimensions of approximately
90 x 90 x 40 gm.
The pointed tip of a 26 gauge hypodermic needle was gently sanded to provide a flat
surface onto which the small diamond chip was glued. The diamond chip was attached
with UV curing epoxy, and cured with a UV lamp for approximately 1 hour. After curing,
the needle tip was cut off from the luer part of the hypodermic needle and glued onto
copper wire with a two-part, 5 minute epoxy (Loctite). The copper wire was affixed to a
3-axis translation stage to scan the diamond through the probe's 3D sampling volume. The
diamond was oriented such the short dimension was in the z-direction.
6.3.2 Experimental procedure
Alignment
Due to the small size scale of the this experiment, proper alignment of the probe, the cover
glass, and the diamond chip is crucial. Comparison of the experimentally measured and
simulated sampling volumes requires accurate knowledge of the experimental coordinates,
especially the z-coordinate. Thus the system must be aligned to ensure that as the diamond
is scanned through the scattering solution, it traces out planes that are parallel to the cover
glass. Furthermore, the probe must be positioned in contact with the cover glass.
A surgical microscope was positioned vertically above the container to aid in the align-
ment. To align the container's cover glass with the stage's x-y plane, the diamond tip was
translated towards the cover glass until it was visually determined to be just in contact; this
contact determination was repeated several times and was repeatable to within 30-40 gm.
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Figure 6-6: A diamond chip mounted on a hypodermic needle used for the sampling volume
experiments. The diamond's dimensions are approximately - 90 x 90 x 40 gm.
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The process was repeated at different locations on the x-y plane, and the tilt/rotation stage
was adjusted until, for the corners of a 2 x 2 mm square, all four contact points were within
20 gm of each other. The probe was placed in contact with the cover glass by visualizing it
with the surgical microscope and a magnifying glass.
Data acquisition
Prior to data acquisition, calibration spectra were acquired, including an acetaminophen
spectrum for wavenumber calibration and a dark spectrum.
The diamond was positioned in contact with the cover glass, and then translated 100
gm away from the cover glass, in the positive z-direction, to avoid accidental loss of the
diamond or scratches on the cover glass. The diamond was then manually translated in the
x-y plane to maximize the Raman signal from the diamond; this position was taken to be
(x = 0,y = 0).
Raman spectra were acquired as the diamond was traced through a 200 x 200 x 200 jim
volume, with a step size of 20 jim in all dimensions. At each location, 10 frames of data
were taken at 0.25 seconds per frame. Sampling volume measurements were repeated for
both scattering phantom solutions at least two times.
Data processing
The Raman spectra were processed using the same preprocessing steps described in Chapter
2, including cosmic ray filtering, frame averaging, and PRNU correction. Because the probe
illuminates the CCD differently from the benchtop system, a new PRNU correction factor
was estimated, as described in Appendix A (Figure A-6).
A typical spectrum is shown in Figure 6-7. As expected, this spectrum exhibits the
strong diamond band at 1332 cm - 1, as well as a broad background resulting from both the
cover glass and fluorescence from the ink in the phantom solution. To extract the diamond
band, a straight line was subtracted from the data between 1293 and 1366 cm - 1. The
maximum value of the band was taken as the magnitude of the diamond signal.
6.3.3 Simulation procedure
All computations were performed on a computer running Windows XP, equipped with an
Intel Core 2 Quad CPU (Q9300) and 2 GB of RAM.
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Figure 6-7: Data processing for diamond sampling volume experiments. The preprocessed
spectrum is shown in blue. A linear background (red) was subtracted from the spectrum
to determine the magnitude of the diamond Raman signal.
6.3.4 Zemax model
The experimental probe geometry was created in Zemax (Figure 6-8). The fibers were
represented by concentric cylinders representing the core, cladding and buffer of the fiber,
and the filter was a single piece of fused silica. In the fabricated probe, the collection fiber
was offset from the filter by 50 gm, so this was added to the Zemax model. Additionally,
epoxy was included in the model, surrounding the distal tip of the fibers.
Collection fiber
Excitation fiber
Epoxy
Filter
Figure 6-8: Zemax probe geometry for sampling volume experiments.
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MCML model
MCML is programmed to allow the user to define a series of semi-infinite layers to represent
the sample. To model the experimental sample, we defined a two-layer model, where the
top layer is the cover glass and the bottom layer is the phantom solution. In the simulation,
the thickness of the phantom layer was set to be arbitrarily large at 5 cm. The MCML
model parameters are shown in Table 6.2.
Table 6.2: MCML model input parameters for the sampling volume simulations.
n A1a [cm 1 ] ps [cm - 1 ] g d [cm] Comment
1.0 n for medium above (air)
1.515 0 0 - 0.015 Cover glass
1.33 ga s  5 Scattering medium (see Table 6.1)
1.0 n for medium below (air)
For each set of optical properties, the simulations were performed twice, using two
scattering phase functions: the Mie phase function, which is accurate for the polystyrene
microsphere solution, and the Henyey-Greenstein phase function, a commonly used approx-
imation (Eq. (6.8)). At each scattering step of the simulation, a random deflection angle
is generated from the chosen phase function, using the inverse cumulative density function
(CDF) technique [123]. The CDF of the Henyey-Greenstein phase function is analytically
invertible, but the CDF of the Mie phase function is not. Thus Monte Carlo simulations uti-
lizing the Mie phase function require a table lookup step, increasing the total computation
time.
For the 1 gm diameter microspheres used in the these validation experiments, the two
phase functions are similar for both the excitation and collection wavelengths (Figure 6-
9). The primary difference is that the Henyey-Greenstein phase function has a higher
probability of forward scattering for very small deflection angles (¢ < 12'), while the Mie
phase function has higher probability for q E (120, 400).
Step 1: Propagate excitation light to interface plane
While the simulation procedure in Section 6.2.1 calls for the use of Zemax to propagate from
the excitation laser to the probe/sample interface plane, the experimental probe geometry
was simple enough that Zemax was not necessary. The output of the single mode fiber is a
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Figure 6-9: Mie and Henyey-Greenstein phase functions for 1 gm diameter polystyrene
microspheres in water.
Gaussian beam with mode field diameter 5.6 pm and numerical aperture 0.12, which then
travels through the optical filter to the interface plane. Using ABCD matrix analysis or
divergence analysis for Gaussian beams [124], we determine that at the interface between
the probe and the coverglass, the beam waist is w = 39 im.
Step 2: Propagate excitation light into tissue
MCML was used to simulate the propagation of the excitation light within the tissue. Two
million input rays were generated, each with unit weight, to simulate a Gaussian beam with
the calculated beam waist. Each ray's position was generated randomly from a 2D Gaussian
distribution:
2P 2p2
I(p)= 2P exp [- (6.18)
where p = Vx 2 + y2 and P is the beam power, set to unity. The initial propagation
direction of each ray was determined based on the ray's radial position, p. The initial
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deflection angle, 0, was calculated as
sin(P) = (6.19)R1
and the azimuthal angle, 0 was defined to be radially outward,
tan(O) =-. (6.20)
The modified MCML was used to propagate the excitation rays, using the parameters in
Table 6.2. Absorption in each 10 x10x 10 gm voxel was recorded, yielding ERaman,gen(X, y, Z).
The computation time for step 2 was approximately 30 minutes using the Henyey-Greenstein
phase function, and 45 minutes using the Mie phase function.
Step 3: Propagate isotropically emitted Raman photons to interface plane
We defined Raman point sources as being 10 x 10 x 10 jim voxels. All point sources were
centered at x = 0 and y = 0. Because the cover glass occupied the first 150 gm of the
sample geometry, point source voxels were generated to span z = 150 gm to z = 560 gm,
for a total of 41 point sources. For each point source, two million photons were initialized,
each with a uniformly distributed random position within the voxel and an isotropically
distributed propagation angle. The photons were propagated to the interface plane using
the modified MCML. Because MCML uses only one CPU core, the 41 point sources were
split into four groups, and each group was then assigned to one core. The total computation
time for step 3 was approximately 3 - 4 hours using the Henyey-Greenstein phase function
and 7 - 9 hours using the Mie phase function.
Step 4: Propagate Raman photons from interface plane through probe
Because this probe geometry consists only of a flat filter, the collection profile for the
collection fiber, ERaman,coll(X y, z), is radially symmetric with respect to the center of the
collection fiber. We exploited this radial symmetry to reduce the computation, by only
propagating Raman photons from isotropic point sources located in a single quadrant under
the collection fiber. Additionally, because ERaman,colI(X y, Z) is a smoothly varying function,
we further reduced the computation by shifting the point sources in x and y by 20 jm steps,
and then interpolating the results to determine ERaman,coll( y, Z) on the desired 10 x 10 x 10
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jim grid. The total computation time for step 4 was approximately 12 hours for each phase
function.
Step 5: Calculate the sampling volume
Finally, MATLAB was used to multiply the excitation profile from step 2 by the collection
profile from step 4, to determine the sampling volume profile, ERaman,sampling volume(X, Y, z).
To compare the simulation results with the the experimental results, the finite size of the
diamond was accounted for by convolving the calculated sampling volume with a matrix of
ones corresponding to the size of the diamond. Computation time for step 5 was approxi-
mately 15 minutes for each phase function.
6.4 Results
6.4.1 Simulation results
The simulation results are shown in Figures 6-10 (property set A, ps = 200 cm - 1 , Henyey-
Greenstein phase function), 6-11 (property set B, ps = 100 cm - 1 , Henyey-Greenstein phase
function), 6-12 (property set A, Mie phase function), and 6-13 (property set B, Mie phase
function), with identical colorscales to aid in the comparison of the results. The Raman
source, ERaman,gen(X, y, Z), is symmetric about the excitation fiber's central axis, so cross-
sections of the profile are shown in (Figures 6-10(a), 6-11(a), 6-12(a), and 6-13(a)). The
numerical values shown are not physically relevant. For both phase functions, within the
top 50 jim of the phantom, the Raman source profile for property set A is approximately 1%
greater than for property set B. Furthermore, the source profile for property set B extends
to a deeper depth (50% of the maximum value around 280 jim) than for property set A (50%
around 250 gm). These results are explained by the difference in the scattering coefficient
between property sets A and B. Because property set A has a higher value for ps, photons
travel a shorter distance before being absorbed, which increases the number of absorbed
photons near the top of the phantom. The lower value of ps in property set B allows
the photons to propagate further without changing direction, which explains B's narrower,
deeper Raman source profile. Although the Mie and Henyey-Greenstein phase functions
give qualitatively similar results, at deeper depths, the Raman source profile calculated
using the Henyey-Greenstein function is up to 40% higher than the Mie function profile.
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The discrepancy increases with increasing depth.
The Raman collection profiles, ERaman,coll(X, y, z), are shown in Figures 6-10(b), 6-11(b),
6-12(b), and 6-13(b). The collection profile is symmetric about the collection fiber's central
axis, and the numerical values in ERaman,coll(X, y, z) represent the collection efficiency for
photons generated isotropically within a voxel centered at (x, y, z). The collection profile
for property set B extends deeper into the phantom than for property set A, and the overall
shape is narrower and less rounded than A. Additionally, the profile for property set A
is higher in magnitude in the central region of the fiber, at all depths. Again, the Mie
and Henyey-Greenstein phase functions yield qualitatively similar results. Quantitatively,
within the top -100 gm, the Mie phase function has a lower magnitude collection profile,
but at deeper depths, the Mie function yields up to 10% higher collected signal magnitude.
Finally, the Raman sampling volumes, ERaman,sampling volume(X, y, Z), are shown in Fig-
ures 6-10(c), 6-11(c), 6-12(c), and 6-13(c), after convolution to account for the diamond size
and shape. The numerical values are not physically meaningful. The sampling volume is
not symmetric, so slices representing the x-plane and y-plane are shown. In the x-plane,
the sampling volume is symmetric about the depth axis, and in the y-plane, the sampling
volume is skewed towards the collection fiber; this leads to elliptical contours in each z-
plane (not shown). Again, the sampling volume for property set B extends deeper into
the tissue and is narrower than for property set A, which is shallower and more rounded.
The convolved sampling volumes show qualitative differences between the Mie and Henyey-
Greenstein phase functions. The Mie sampling volume decays faster and has a maximum
at a deeper depth than the Henyey-Greenstin sampling volume, possibly due to the smaller
forward scattering of the Mie phase function.
6.4.2 Experimental results
The experimental sampling volume results are shown in Figures 6-14 and 6-15, with identical
colorscales to aid in comparison. The numerical values correspond to CCD counts of the
magnitude of the diamond spectrum. At each depth, the contours of the diamond signal
exhibit an elliptical shape, as predicted by the simulations. Serendipitously, the major
and minor axes of the ellipses also lie along the experimental system's x and y axes, so
no rotation of the experimental dataset was necessary to compare the simulated results.
For both optical property sets, experimental data was acquired within the same volume, a
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Figure 6-10: Simulated sampling volume for property set A (/st = 200 cm-1), with Henyey-
Greenstein phase function. (a) Raman source profile, (b) Raman collection profile, and (c)
Raman probe sampling volume, after convolution.
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Figure 6-11: Simulated sampling volume for property set B (/s = 100 cm-1), with Henyey-
Greenstein phase function. (a) Raman source profile, (b) Raman collection profile, and (c)
Raman probe sampling volume, after convolution.
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Figure 6-12: Simulated sampling volume for property set A (p = 200 cm-1), with Mie
phase function. (a) Raman source profile, (b) Raman collection profile, and (c) Raman
probe sampling volume, after convolution.
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Figure 6-13: Simulated sampling volume for property set B (/As = 100 cm-1), with Mie
phase function. (a) Raman source profile, (b) Raman collection profile, and (c) Raman
probe sampling volume, after convolution.
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Figure 6-14: Experimentally measured sampling volume for property set A (ps = 200 cm-1).
(a) Diamond signal (CCD counts) for multiple depths. (b) Diamond signal in the x-plane
and y-plane. White isocontour lines represent 75%, 50%, and 25% of the maximum value.
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Figure 6-15: Experimentally measured sampling volume results for property set B (ps = 100
cm - 1. (a) Diamond signal (CCD counts) for multiple depths. (b) Diamond signal in the
x-plane and y-plane. White isocontour lines represent 75%, 50%, and 25% of the maximum
value.
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Figure 6-16: Comparison of experimental and simulated sampling volumes for property set
A (ps = 200 cm-1), with Henyey-Greenstein phase function.
144
100
Simulation
- .-- Experiment 1
- --- Experiment 2
---- Experiment 3
cover
RMS error = 2.0%
---i- ---- -. .-;i-----
x [jim]
0
50
100
150
200
E
250
300
350
400
450
100
500 -
-100
y [jIm]
(a) Isocontours at 75%, 50%, and 25% of the maximum value at z = 250 micron.
0.5
100 200 300 400
Depth, z [gm]
(b) ERaman,sampling volume(X = 0, y = 0, Z)
Figure 6-17: Comparison
B (p, = 100 cm-'), with
of experimental and simulated sampling volumes for property set
Henyey-Greenstein phase function.
145
-100 100
500
Simulation
---- Experimenti I: i !: i i: ! i i iii !i i i ii i: il i i i i ) ii/ i i
i :!i!,!:i i : iii i !i i ;ii , ............. :i   iii- i: (
-j 500
100 -100
y [tm]
(a) Isocontours at 75%, 50%, and 25% of the maximum value at z = 250 micron.
100 200 300 400
Depth, z [ltm]
(b) ERaman,sampling volume (= 0, y = 0, z)
500
Figure 6-18:
A (ps = 200
Comparison of experimental and simulated sampling volumes for property set
cm-1), with Mie phase function.
146
50
100
150
200
E
. 250
300
350
400
450
50
100
150-
200-
250 -
300
350
400
450
500
-100
x [pm]
100
1
0.5
cover glass
0-
50
100
150
200
= 250
300
350-1
400
450
500 -
-100
0-
50
100
150
200
E
. 250
300
350
400
450
500 -
-100
x [p~m]
(a) Isocontours at 75%, 50%, and 25% of the maximum value at z = 250 micron.
0 100 200 300 400
Depth, z [jim]
(b) ERaman,sampling volume(X = 0, y = 0, Z)
Figure 6-19: Comparison
B (p, = 100 cm-1), with
of experimental and simulated sampling volumes for property set
Mie phase function.
147
100
y [gm]
100
500
200 x 200 x 200 um cube, with a step size of 20 gm. At the top of the measured volume
(z = 250 [m), the sampling volume in property set A is greater in magnitude than in B,
as predicted by the simulations. Additionally, A's sampling volume decays faster in depth
than B's. Isocontours representing 75%, 50%, and 25% of the maximum signal value are
displayed in the x-plane and y-plane images.
6.4.3 Comparison between simulation and experiment
The diamond signal isocontours can be used to qualitatively assess the agreement between
the experimentally and simulation derived sampling volumes (Figures 6-16(a), 6-17(a), 6-
18(a), and 6-19(a)). Contours were calculated as 75%, 50%, and 25% of the maximum
signal at the depth z = 250 gm. In all cases, good agreement is seen between the simulation
and experimental contour values, though the Henyey-Greenstein phase function appears to
yield better agreement than the Mie phase function.
For quantitative comparison, we plot the simulated and experimentally measured one-
dimensional depth profile, ERaman,sampling volume(X = 0, y = 0, z) (Figures 6-16(b), 6-17(b),
6-18(b) and 6-19(b)). All values were normalized to the value at z = 250 gm. The results
from three experimental repetitions of property set A, taken within the same experimental
session, and two repetitions of property set B, taken on different days, demonstrate that the
experiments are highly repeatable. Simulations using the Henyey-Greenstein phase function
yield better agreement with the experimental sampling volume, with an RMS error of 2%
for property set A, and 4% for property set B. In comparison, the Mie phase function results
have an RMS error of 8% for both sets of optical properties. However, for z > 300 gm,
the slope of the experimental results appears to be offset from the simulation curve. By
normalizing the results to the value at z = 310 gm, the RMS error is reduced to 3% for
both property sets (Figure 6-20). This phenomenon is discussed further in the next section.
6.5 Discussion
In this chapter, we have developed a Monte Carlo model for Raman scattering, and used it
to simulate the sampling volume of a Raman probe. The simulation technique considers the
propagation of both the excitation light and the returning Raman light, which is important
because both beam paths may be affected by the addition of distal optics on the probe tip.
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Furthermore, the model treats the excitation and collection beam paths separately, so it is
only necessary to simulate the isotropic emission of Raman photons once for a given set of
optical properties, which reduces the total computation time.
We have experimentally validated this Raman optical simulation technique by using a
diamond chip mounted on a needle to measure the sampling volume of a two-fiber Raman
probe. The small diamond chip was swept through a scattering phantom solution, while
the magnitude of the diamond Raman signal was measured. The phantoms were aqueous
solutions of polystyrene beads and india ink, with two distinct sets of optical properties
chosen within the range of optical properties for aorta. For both phantoms, the simulated
and experimentally measured Raman sampling volumes show good agreement.
There are several potential explanations for the discrepancies between the simulated
and experimental sampling volume results. The most important is geometry discrepancies.
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The Raman probe is small - the outer diameter of the optical fibers in the probe is
approximately 200 Ctm. At this size scale, it is likely that the probe was not fabricated to
the desired specifications. Indeed, while both fibers were meant to be bonded in contact
with the filter surface, in the fabricated probe, the collection fiber was offset from the
filter surface by 50 ginm. Another potential discrepancy is in the positioning of the diamond
relative to the container's cover glass. While we believe that we have accurately determined
the z location of the diamond, this measurement could be off by up to ~20 gm.
Another important difference between the simulations and experiments lies in the way
the diamond was modeled in the simulation. We simulated the Raman sampling volume
for a medium with homogeneous optical properties, and then accounted for the diamond
by convolving the simulation results with a uniform 3D kernel representing the size and
shape of the diamond. However, in the experimental setup, the diamond is a 90 x 90 x
40 gm inclusion with distinctly different optical properties from the phantom solution;
the index of refraction for diamond is ~2.4 and diamond has no scattering or absorption
at this wavelength. Additionally, the diamond chip does not have regular facets, further
complicating the optical geometry.
We have performed simulations using both the Henyey-Greenstein and Mie scattering
phase functions. While the Mie phase function is accurate for the polystyrene bead solu-
tion, it is more computationally intensive, and thus the Henyey-Greenstein approximation
is often used. Compared to the Henyey-Greenstein simulations, the sampling volume sim-
ulations using the Mie phase function better match the trends seen in the experimental
sampling volumes for z > 300 gm, which is expected since the Mie phase function more
accurately describes scattering in the phantom solutions. This effect is most noticeable in
property set B; in property set A, simulation results from both phase functions match the
experimental results well. This is likely due to the overall increased scattering in A, where
the collected photons have undergone so many scattering events that the minor differences
in the two phase functions become less important. However, the Mie phase function sim-
ulations exhibit a discrepancy with the experimental results at shallower depths, possibly
because at shallower depths, the diamond inclusion boundary effect described above is dom-
inant. Again this boundary effect is less prominent in property set A than in B, due to the
increased average number of scattering events in A.
The Raman optical simulation technique may be a valuable tool for evaluating and
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optimizing Raman catheter designs. There are several possible performance metrics for
choosing the "optimal" design, the most obvious being some measure of collection efficiency
or total Raman intensity. However, sampling volume is also important, and it is possible
that targeting a specific Raman sampling volume may be an important design specification,
in addition to maximum collection efficiency.
For example, in a scanning catheter, the catheter's sampling volume will determine the
sampling rate needed to effectively screen a large segment of the artery. The sampling
volume is likely to be important diagnostically as well; the interpretation of the Raman
spectrum originating from a deep, narrow sampling volume is different from the interpreta-
tion of a shallower, wider sampling volume. The Raman optical simulation technique is an
ideal platform for addressing these design questions.
There are several design parameters that can be optimized using the Raman simulation
technique. For example, the optical fiber diameter and density directly affects the probe's
sampling volume. Choosing fibers with increased numerical aperture may increase the
amount of accepted Raman light. Furthermore, due to the Raman catheter's small size
scale, the distal optical elements required to implement a side-viewing geometry are likely to
be custom-fabricated, and the Raman simulation technique provides a means for designing
such custom mirrors, lenses, and prisms.
Additionally, the Raman simulation technique can be used to determine fabrication
tolerances for the catheter components. For example, because the Raman probe diameter
is < 1 mm and the optical components are on a sub-millimeter size scale, misalignment
during fabrication is likely. The simulation technique can be used to perturb the probe
design through translations and tilts of the optical components. In this way, the simulations
can be used to choose optical designs that are relatively simple to fabricate and robust to
fabrication errors, giving high yield in the fabricated probes.
6.6 Conclusion
In this chapter, we have developed and experimentally validated a Raman optical simula-
tion method that can be used to assess the sampling volume and collection efficiency of
a Raman probe. The simulated and experimentally measured sampling volumes for two
tissue-mimicking phantoms show good agreement. The simulation technique can be used to
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design an optimal Raman catheter, based on the catheter's predicted sampling volume and
collection efficiency over the range of expected catheter-tissue separation geometries and
optical properties. Other potential uses of the simulation technique include designing cus-
tom optical elements for the catheter and determining fabrication tolerances in the catheter
design.
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Chapter 7
Conclusions and Future Directions
Atherosclerosis, a leading cause of death in industrialized nations, is an inflammatory disease
of the arteries, characterized by the development of atheromatous plaques within the arterial
wall. Rupture of these plaques and the resulting thrombosis can occlude flow and may
ultimately result in myocardial infarction. The mechanism behind plaque progression and
disruption is not well understood, but lesion structure, molecular and chemical composition,
biomechanical behavior, and functional state are believed to be important. In this thesis, we
have investigated Raman spectroscopy as a means for assessing the chemical composition
of atherosclerotic plaques. Raman spectroscopy is an optical technique for determining
the chemical composition of a sample based on spectral analysis of inelastically scattered
photons. As a vibrational spectroscopy technique, Raman is sensitive to both the molecular
composition and molecular structure of the sample being interrogated and is thus highly
sensitive to chemical changes due to disease pathology.
In this thesis we have investigated several improvements aimed at developing a clinically
viable intracoronary Raman system, including high wavenumber Raman, Raman line imag-
ing, and optical modeling for improving catheter design. We investigated HW Raman and
Raman line imaging through the creation of an ex vivo Raman database, consisting of FP
and HW Raman line images with correlated histology for 69 aortic lesions. Rigorous data
acquisition, validation, and documentation procedures were implemented to ensure that all
specimens had high quality spectral and histological data and that the spectral acquisition
sites were accurately registered with the histology. All data was captured electronically,
and a graphical user interface was developed to enable easy visualization of all the data for
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each specimen on a single screen, which ultimately aided in the lesion characterization data
analysis. To date, 69 lesions have been acquired from nine subjects, mostly representing a
range of lipid-rich lesions. Future work includes increasing the number of specimens and
subjects in the database.
To analyze the database spectra, we developed a spectral model consisting of basis
spectra representing the most important chemical components in the arterial wall. The
model included free cholesterol, cholesterol ester, triglyceride, and two separate protein
components. Additionally, the FP model contained -carotene and calcification, both of
which have no spectral features in the HW region. The model was fit to the database spectra
and was found to accurately account for all the significant bands in the FP and HW Raman
spectra. A subset of the model fit coefficients were retained for lesion characterization: free
cholesterol, cholesterol ester, protein, and calcification (FP only).
A subset of the database spectra were selected to create a single site Raman database,
which were histologically classified into calcified, non-lipid, and lipid-rich lesions. The model
fit coefficients were used to diagnose these sites based on the FP and HW Raman spectra.
By calculating and thresholding the lipid-to-protein ratio, defined as the sum of the free
and esterified cholesterol coefficients divided by the sum of the protein coefficients, spectra
from both the FP and HW Raman regions were capable of diagnosing lipid-rich lesions,
with sensitivity/specificity of 88%/84% and 95%/85%, respectively.
While both the FP and HW regions are capable of diagnosing lipid-rich vs. non-lipid le-
sions, each region has several advantages and drawbacks. The HW spectra exhibit increased
Raman signal over the FP spectra. Additionally, the HW region has an easier to remove
background spectrum, due to both reduced fluorescence and the fact that many of the opti-
cal components that contribute to the background in the FP region have a negligible signal
in the HW region. Furthermore, the HW spectra have fewer spectral features than the FP
region, so fitting HW spectra to the spectral model is easier. However, the HW region has
two significant drawbacks: it cannot be used to detect the presence of calcifications, and it
is not highly sensitive to cholesterol vs. cholesterol esters.
In contrast, the fingerprint region, as its name implies, is sensitive to minor differences
in molecular composition and structure, such as between cholesterol and cholesterol esters,
and the FP region can be used to detect the presence of calcification. However, the in-
creased sensitivity and increased number of Raman bands in the FP region also makes the
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spectral model more sensitive to errors in determining the model basis spectra. Even worse,
there are more possible sources of error in the FP region than in the HW region. First,
basis spectra not acquired from samples in situ may exhibit spectral shifts due to environ-
mental conditions, and because the FP spectra have sharp bands, these spectral shifts can
potentially be extremely damaging to model accuracy. Further, comparison of relative FP
band intensities relies on accurate background subtraction, which is more difficult in the
FP region because of increased fluorescence and the possibility of contamination by Raman
and fluorescence arising from optical components in the Raman system. Finally, FP spectra
have less signal than HW spectra and thus lower SNR. Thus, while the FP region has more
information than the HW region, it is also more prone to confounding effects that introduce
errors.
The database data was also used to assess the utility of Raman line imaging. Raman
line images provide a more complete characterization of heterogeneous lesions than single
site spectra. By simple visual inspection of the spectral model fit coefficients as a function
of position, it possible to determine the presence and size of an atherosclerotic lesion.
We then turned our attention to the development of a fiber optic Raman catheter. A
significant technical challenge in FP Raman probe fabrication is the need for two distinct
distal optical filters to avoid contaminating the tissue Raman signal with a large background
arising from the silica fiber. Through the use of a patterned monolithic optical filter, we
designed a 775 gm diameter Raman probe that is simpler to fabricate than previously
demonstrated Raman probes.
In the most common intravascular catheter-based imaging paradigm, a sub-millimeter
catheter is free-floating within the lumen of a 2 - 3 mm diameter artery; thus the distance
between the probe and the tissue surface is variable due to lateral catheter motion. For this
reason, we assessed Raman signal collection as a function of distance between the probe
and the tissue surface, with both saline and blood as the intervening medium. Due to high
blood absorption, the probe was not capable of acquiring tissue Raman spectra through
more than -500 gim of blood, suggesting that successful intracoronary Raman spectroscopy
will require the use of either a contact catheter or a saline flush to purge the blood prior
to spectral acquisition. Tissue Raman spectra were reliably obtained through -2 mm of
saline.
The Raman probe was incorporated into a side-viewing Raman catheter by adding a
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450 mirror and enclosing the assembly in an outer sheath, and this side-viewing Raman
catheter was tested in a swine xenograft model. In this model, human coronary arteries
obtained from cadaver are grafted onto a living swine's circulatory system, enabling test-
ing of intracoronary devices for assessing real human pathology in an environment closely
resembling human coronary physiology. The side-viewing Raman catheter was able to ac-
quire interpretable Raman spectra with an integration time of 4 s, albeit with relatively low
SNR. In the low SNR environment provided by the catheter, the technical advantages of the
HW region stand out. The higher magnitude signal in the HW region combined with the
relatively featureless background make HW data analysis simpler than in the FP region.
We developed a Raman Monte Carlo model for Raman scattering, and utilized it to
develop a simulation technique for modeling catheter performance and optimizing catheter
design. The modeling technique considers both propagation of the excitation beam and
resulting generation of Raman scattered light, as well as the propagation of the returning
Raman light. In our implementation, we have incorporated two software packages, a Monte
Carlo package for accurate modeling of optical propagation in tissue, and a commercial
ray tracing package for accurate modeling of propagation through complex optics. By
simulating all aspects of Raman generation and propagation, the modeling technique can
assess the sampling volume and collection efficiency of an arbitrary Raman probe.
We experimentally validated our simulation technique by measuring the sampling vol-
ume of a two-fiber Raman probe. A small diamond chip was treated as a Raman point
source and immersed in a scattering phantom solution. The Raman probe then measured
the magnitude of the diamond signal as the diamond was scanned through the probe's sam-
pling volume. For two different phantom solutions with optical properties similar to human
aorta, the experimental and simulation derived sampling volumes show good qualitative
and quantitative agreement.
Future work includes using the validated Raman optical simulation technique to opti-
mize Raman catheter design, through optimization metrics such as sampling volume and
collection efficiency. Several alternate optical designs will be explored, including the use of
custom distal optical lenses to increase collection efficiency. The simulation technique will
also be used to assess probe performance through the range of environmental conditions
expected for the probe, such as varying catheter-tissue distance.
The lesion characterization techniques described in this thesis can be expanded into
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several interesting directions. For example, quantitative analysis of the spatial information
in the Raman line images is expected to enhance lesion characterization and may even be
able to identify markers for lesion vulnerability based on spatial changes in lesion compo-
sition. In addition, the spectral model can be refined and externally validated to enable
more detailed spectral decomposition of lipids, particularly cholesterol and the individual
cholesterol esters, which are thought to be important during lesion development.
The Raman line images in the ex vivo database form the beginnings of a platform for
further development of characterization algorithms and for testing the existing hypotheses
relating chemical composition to lesion morphology. However, more subjects need to be
incorporated into the database to achieve statistically significant numbers for each lesion
type and to address inter-patient variability.
In the longer term, an intracoronary Raman spectroscopy system has several potential
applications. Raman spectroscopy is already capable of diagnosing calcified, non-lipid,
and lipid-rich plaques ex vivo; a viable catheter-based Raman system will enable in vivo
diagnosis. Furthermore, a viable in vivo Raman system will allow for longitudinal studies of
atherosclerosis, enabling chemical mapping of the same subject at the same location, over
multiple time points. Longitudinal studies for studying lesion progression in the context
of chemical composition may aid in the understanding of the disease. The Raman system
can also be used to assess long-term efficacy of treatments for atherosclerosis, such as lipid-
lowering drug therapy and stents.
In summary, in this thesis we have investigated methods that may further the develop-
ment of clinically viable intracoronary Raman spectroscopy. We have created a database of
FP and HW Raman line images with correlated histology and used it to assess the relative
merits of the FP and HW regions for lesion characterization. Both regions have similar
diagnostic capability for detecting non-lipid vs. lipid-rich plaques, but only the FP region
has sensitivity to calcification. In general, the FP region has higher molecular specificity
than the HW region, but that same property makes FP spectra more difficult to analyze
than HW spectra, especially in a low SNR regime. The HW region is simpler to work with,
both in terms of data analysis and catheter design. Ultimately, the determination of which
wavenumber region to use depends on whether the enhanced chemical information in the FP
region is more clinically valuable than the ease-of-use offered by the HW region. In either
case, a Raman catheter is needed, and to that end, we have developed a validated Raman
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optical simulation technique to guide probe design. The union of the work presented in this
thesis provide useful insights toward solving the challenges in developing a catheter-based
intracoronary Raman system.
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Appendix A
Photoresponse Non-Uniformity
The raw spectral data exhibit a high frequency signal variation that can obscure narrow, low
intensity Raman bands. Photoresponse non-uniformity, or pixel response non-uniformity
(PRNU), arises from imperfections introduced during the CCD array fabrication process.
As a result, the quantum efficiency of each pixel is nonuniform, so even when the CCD
array is uniformly illuminated with a fixed-intensity signal, the measured signal is not
uniform [125].
In general, a common method of correcting for PRNU is to perform flat-field normaliza-
tion, i.e. divide each data image by a flat-field image acquired with the CCD illuminated
by a uniform light source. In Raman spectroscopy, the analogous approach is to acquire the
spectrum of a diffusely reflected white light source. A typical configuration it is to place
packed barium sulfate (BaSO 4) powder, a reflectance standard that reflects uniformly over
our wavelength range, at the system's focal plane and illuminate it with a tungsten white
light source. An important feature of this configuration is that the illumination conditions
closely match the experimental conditions of the returning Raman light. Incoming data
spectra are divided by a normalized version of this white light spectrum, thus correcting
for both PRNU and the system's spectral response simultaneously.
In practice, this procedure is not straightforward. The white light spectrum is highly
dependent on the orientation of both the tungsten source and the BaSO4 sample. Figure
A-1 shows eight white light spectra taken on six different days. All eight spectra have
different spectral features, even the three spectra taken on the same day (Figure A-1(b)).
This is undesirable for a standard.
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Figure A-i: (a) White light spectra taken with the benchtop Raman system on different
days. Three spectra from a single day are shown in (b); these were taken with the white
light source held at varying distance and angle with respect to the BaSO 4, giving varying
levels of overall intensity and noticeably different spectral shapes.
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Simply dividing the data by a white light spectrum taken on the same day does not seem
to be the best way to correct to for PRNU. While the white light spectrum is expected to
have a smooth, low order polynomial shape, the measured white light spectra exhibit extra
variation, with a period of approximately 50 pixels, throughout the spectrum (most readily
apparent on three highest intensity spectra of Figure A-1(a)). Dividing the data by the
white light spectrum note only removes PRNU, but also adds uncharacterized frequency
dependent variation to the processed data.
Instead, we use the white light spectra to estimate PRNU correction factors, which we
then use to remove PRNU from our data. For notational simplicity, we will refer to this
correction factor as quantum efficiency, q. 1 We assume that our measured spectrum, Sm(w),
is related to the real spectrum of the light impinging on the CCD, So(w) by
Sm(W) = So(w>)(w). (A.1)
In the benchtop Raman system, each pixel corresponds to a particular frequency range, so
the variable w is also standing in for column location on the CCD. We wish to calculate
77(W) = S ) (A.2)
so(P)
but So(w) is unknown and thus must be estimated.
To determine So(w), the estimate of So(w), we first subtract the dark spectrum from
the white light spectrum to remove the CCD's fixed offset signal. Next, we estimate So(w)
by locally fitting a polynomial to the measured Sm(w). We assume that So(w) is smoothly
varying, i.e. there are no sharp peaks in the spectrum. We choose a small moving window
(- 100 pixel length) of the measured spectrum, Sm(w), and fit a fifth order polynomial to
estimate So(w) within each window. So(w) is constructed by selecting the central portion of
the polynomial fit for each window, which avoids edge effects in the polynomial fits (Figure
A-2).
Finally, we calculate
So(w)O(w) = Sm (A.3)
In Figure A-3, we have estimated f(w) for all eight white light spectra shown in Figure A-1.
1Technically, we are estimating a quantity presumed to be proportional to the quantum efficiency, not
the actual quantum efficiency
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Figure A-2: An example estimate of So(w). The original white light data is shown in
blue. The central portion of the windowed polynomial fits (cyan) were selected to estimate
So(w) (red). Overlapping windows were necessary to avoid edge effects in the windowed
polynomial fits.
The calculated i values are similar for all eight white light spectra, and ij ranges from 0.96
to 1.04 for all pixels. The standard deviation of 7i for the eight spectra is less than 0.01 for
all pixels. Figure A-3 depicts the 7i that was used for the database data.
Despite these differences in quantum efficiency being subtle, they have significant impact
on the data. Some examples of corrected database data are shown in Figures A-4 and A-
5. For display, the PRNU-corrected spectra have also been filtered with a Savitkzy-Golay
filter [102, 126] with a polynomial order of 2 and frame size of 11. The filter is built into
MATLAB's Signal Processing Toolbox (sgolayf ilt).
The calculated PRNU correction factor is specific to the CCD used to acquire the data.
Furthermore, since spectra are typically acquired by vertically binning some or all of the
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Figure A-3: i for the database data. In (a), colored lines represent calculated for same
color white light spectrum in Figure A-1(a). In (b), the mean i value for the eight white
light spectra is shown, as well as the standard deviation, offset by 0.95.
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Figure A-4: Example of PRNU correction on database data (specimen UMD019). The orig-
inal data (blue), after PRNU correction (green), and after Savitzky-Golay filtering (black).
All spectra are offset for clarity.
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Figure A-5: Example of PRNU correction on database data (UMDO20). The original
data (blue), after PRNU correction (green), and after Savitzky-Golay filtering (black). All
spectra are offset for clarity.
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rows on the CCD, the correction factor is dependent on the illumination conditions. Even if
all rows are included in the binned measurement, illuminating the top half of the chip will
result in a different i than illuminating the bottom half, because the quantum efficiencies
of different pixels are being incorporated into the measurements.
It is not necessary to use white light spectra to calculate PRNU correction factors; any
spectrum with either a known spectral shape or a smoothly varying spectral shape that can
be estimated is suitable for estimating i.
The Raman probe sampling volume experiments in Chapter 6 had different illumination
conditions than the database data, so a new was estimated (Figure A-6(a)). The increased
variation in i across pixels, compared to the database correction factor (Figure A-3), occurs
because the probe illuminates fewer rows of the CCD. PRNU correction was vital in this
case. In one spectrum from the sampling volume experiments, two small Raman peaks
that were not discernible in the frame averaged data become readily apparent in the PRNU
corrected data (Figure A-6(c)).
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Figure A-6: PRNU correction on sampling volume data. (a) Correction factor for the
sampling volume experiments of Chapter 6. (b) Raw data for an example sampling volume
spectrum. The small peaks at 1001 cm - 1 (polystyrene) and 1332 cm - 1 (diamond) become
readily apparent in the preprocessed data in (c). No additional smoothing was performed.
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